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The death and lysis of a subpopulation of cells in Staphylococcus aureus biofilms is 21 
thought to benefit the surviving population by releasing extracellular DNA, a critical 22 
component of the biofilm extracellular matrix. Although the means by which S. aureus 23 
controls cell death and lysis is not completely understood, studies implicate the role of 24 
the cidABC, alsSD and lrgAB operons in this process. This dissertation has focused on the 25 
regulation of cidABC and alsSD expression, which is mediated, primarily, by the LysR-26 
Type Transcriptional Regulator (LTTR) known as CidR. To better define the role of 27 
CidR in regulating cidABC and alsSD transcription we produced a series of mutations in 28 
the cidABC and alsSD promoter regions to identify a putative CidR-binding site, 29 
TAGTA-N-TACAAA. Although CidR was found to directly interact with this site, these 30 
studies also revealed that the induction of cidABC and alsSD transcription is modulated 31 
by two other transcriptional regulators, CcpA and SrrAB, linking cidABC and alsSD to 32 
carbon catabolite repression and respiration. Perhaps most interestingly, a phenotype as-33 
sociated with the cidB was also identified; disrupting cidB in the srrAB mutant back-34 
ground resulted in a decrease in the levels of ROS and sensitivity to ROS, rescuing sta-35 
tionary phase survival. The results of this study further expand upon the cidABC and 36 
alsSD regulatory network of as well as the role this regulon plays in cell death. 37 
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Chapter I:  Literature review 123 
Introduction 124 
Staphylococcus aureus is a Gram-positive pathogen that causes a host of different 125 
human diseases (1), causing greater mortality in the United States per year than HIV (2). 126 
S. aureus colonizes the human nares, pharynx and skin (3, 4). Indeed, 20-30% of the hu-127 
man population is permanently colonized in the nares with S. aureus at any time, with 128 
another 30% of the population colonized transiently (5, 6). While this colonization can be 129 
asymptomatic (7) colonized individuals are at a greater risk for developing S. aureus in-130 
fections (8, 9). Groups with increased risk for infection with S. aureus include military 131 
personnel (10, 11), inmates (12), sports teams (13), as well as the young (2, 14), elderly 132 
(15, 16) and immune-compromised (17, 18). The introduction of penicillin greatly de-133 
creased the mortality rate of S. aureus infections; prior to the development of antibiotics, 134 
the projected mortality of a patient with S. aureus bacteremia was 80% (19). Today, de-135 
pending on the nature of the infection, the mortality rate of individuals infected with S. 136 
aureus can reach 40%, (20, 21). Antibiotic treatment has been complicated by the rise of 137 
community-acquired and hospital-associated strains of S. aureus that are antibiotic re-138 
sistant (2, 22). Shortly after the introduction of penicillin, antibiotic-resistant S. aureus 139 
was formally recognized (23). Similarly, the introduction of methicillin was followed by 140 
the rise of methicillin resistant Staphylococcus aureus (MRSA) (23). Currently the anti-141 
biotic of choice to treat MRSA infections is vancomycin, though there are fears that 142 
vancomycin resistant S. aureus strains may become commonplace (24, 25). With the 143 
growing burden of multidrug resistant MRSA strains and fears about current drugs being 144 
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rendered ineffective for the treatment of staphylococcal disease, research into new alter-145 
native drugs, treatments and a better understanding of how S. aureus causes infection is 146 
necessary.   147 
 148 
Biofilms 149 
A growing concern in S. aureus infection is the increase in chronic infections in pa-150 
tients with catheters or implants (1, 26, 27). S. aureus can cause chronic infections due to 151 
its ability to form biofilms, which are the structured communities of bacteria, held to-152 
gether by a self-produced extracellular matrix (28). Biofilms are formed by many differ-153 
ent species of bacteria, whether pathogens or free living organisms (29). It is believed 154 
that bacteria form biofilms to localize to food sources and protect themselves from the 155 
environment (29). In infections, biofilms afford protection against antibiotics, even if the 156 
bacteria do not possess traditional resistance mechanisms (27). Bacteria in biofilms are 157 
more resistant to clearance (30) because the biofilm cells are not as easily phagocytized 158 
as planktonic cells. Finally, a biofilm can metastasize and spread from the infection site if 159 
not properly treated, leading to bacteremia and seeding of other distal sites (29). Studying 160 
bacterial biofilms and the mechanisms of their formation and maintenance can therefore 161 
lead to a better understanding of how to combat infections. 162 
S. aureus biofilms demonstrate a characteristic sequence of attachment, accumula-163 
tion/maturation, exodus, tower formation and dispersal (31). How S. aureus cells will at-164 
tach depends on whether the target surface is artificial or host tissue (32). On artificial 165 
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surfaces it is believed that the dominant determinants of attachment are hydrophobicity 166 
and Van der Waals forces, mediated by surface proteins, autolysins and teichoic acids 167 
(32). On host surfaces the bacterium will instead use microbial surface components rec-168 
ognizing adhesive matrix molecules, or MSCRAMMs (32). Once cells are attached to a 169 
surface they enter the accumulation/maturation stage. The cells grow and divide, remain-170 
ing connected to each other by the formation of a biofilm matrix. The continued accumu-171 
lation is interrupted by the exodus phase (31), where a subpopulation of cells disperses 172 
from the biofilm, dependent on the activity of a nuclease produced by S. aureus (31). Fol-173 
lowing exodus is maturation, where the remaining cells continue to accumulate and form 174 
microcolonies or tower structures. Maturation is followed by dispersal, where the towers 175 
disintegrate and the cells float away. This final stage is characterized by dependence on 176 
agr and the proteases and nucleases it regulates (33). In an animal host, the dispersal 177 
stage can lead to bacteremia and potentially colonization of other parts of the body (29), 178 
starting the process over again.  179 
 180 
The biofilm matrix 181 
The biofilm matrix is made up of many adhesive molecules, including but not limited 182 
to polysaccharides like PIA, extracellular DNA, and assorted proteins (32). What poly-183 
mer is used and needed can also vary based on the age of the biofilm. The composition of 184 
this matrix can be diverse (34),  varying between strains (35, 36). The primary focus of 185 
the Bayles lab is extracellular DNA, or eDNA, and the regulation of factors that deter-186 
mine when it is released from the bacterial cell. eDNA enters the environment by the 187 
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death and lysis of a subpopulation of the cells (36). The living cells surrounding the lysed 188 
cells use the eDNA as scaffolding within the extracellular matrix. Mutants deficient in 189 
lysis and the release of eDNA are poor biofilm formers, like the murein hydrolase atl (37). 190 
While there have been reports that suggested that atl can act as an adhesin (38, 39), elim-191 
inating the enzymatic activity of Atl via point mutations inhibits biofilm formation (40), 192 
demonstrating that lysis is required for the biofilm to form.  eDNA is most critical for 193 
biofilm formation during initial attachment and accumulation but continues to remain 194 
important as other matrix molecules come into play (36). 195 
Cell death exhibited by S. aureus has been compared to apoptosis in eukaryotes (41, 196 
42). Considering that according to the endosymbiotic theory mitochondria are the rem-197 
nants of long ago phagocytized bacteria (43), this would suggest that programmed cell 198 
death (PCD) in bacteria and apoptosis in eukaryotes share a common evolutionary origin, 199 
and the proteins involved, while having little to no homology, fulfill the same role. This 200 
raises the rather interesting idea that one of the key components of multicellularity, apop-201 
tosis in eukaryotes and PCD exhibited by bacteria, have a common evolutionary origin, 202 
and that the processes that govern PCD appeared long before the appearance of truly mul-203 
ti-cellular organisms. It might be counterintuitive that bacteria would have a means to 204 
commit suicide, as bacterial cells are typically thought of as unicellular organisms. How-205 
ever, a singular bacterium is part of a clonal population (44), particularly in a biofilm. 206 
Low dispersal from sister cells in a biofilm would favor kin selection by means of the 207 
limited dispersal hypothesis (45-49). To put it simply, death mechanisms have a cost to 208 
the individual, but the benefit to the sister cells around a dead cell outweigh the cost to 209 
the individual, leading to its continued selection. 210 
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 211 
The role of cidABC, lrgAB and alsSD in death and the release of eDNA 212 
The processes of death and lysis in S. aureus are influenced by the cidABC, lrgAB 213 
and alsSD operons. Previous work performed by the Bayles Lab has demonstrated that 214 
expression of CidA can be detrimental to the cell (50, 51). Disrupting cidA increases sur-215 
vival of S. aureus RN6390 (50) and UAMS-1 (37) strains and decreases resistance to an-216 
tibiotics (50). Meanwhile, disrupting lrgAB has been demonstrated to have the opposite 217 
effect; disrupting lrgAB transcription increases cell death (52). Investigation into how 218 
CidA could kill the cell and LrgA could protect from death, it was found that both pro-219 
teins are relatively small, possess multiple transmembrane domains, a polar N-terminus 220 
and a highly charged C-terminus. Interestingly CidA and LrgA share these features in 221 
common with bacteriophage holins (53). Based on these findings it was proposed that 222 
CidA and LrgA represent a holin-antiholin system, respectively (37, 50, 52). 223 
First discovered in lytic bacteriophage, holins are proteins that form pores (holes) in 224 
the cell membrane of bacteria (54, 55), leading to the death and lysis of the cell. Death is 225 
potentiated by the activation of an endolysin/murein hydrolase. There are currently two 226 
main models explaining the means by which holins can kill the cell (56). In the lambda 227 
endolysin model the oligomerization of the holin forms a large pore in the cellular mem-228 
brane (57), releasing the endolysin/murein hydrolase from the cytoplasm. Once free of 229 
the cell the murein hydrolase breaks down the peptidoglycan, leading to lysis. In the Sar 230 
endolysin model, instead of releasing the endolysin/murein hydrolase from the cytoplasm, 231 
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the pores formed depolarize the membrane (56), leading to the activation of external 232 
murein hydrolases. 233 
The activity of holins are inhibited by antiholins (55). In phage holins and anti-holins 234 
share a dual-start motif, or two start codons (58). The antiholin is virtually identical to the 235 
holin, typically differing by only the presence of a positively charged amino acid on the 236 
N-terminus of the antiholin. This small but important addition allows the antiholin to in-237 
hibit the oligomerization of the holin. It is thought that CidA, despite sequence similarity 238 
to lambda S holin (56), falls into the Sar endolysin category of holins. It has been pro-239 
posed that the oligomerization of CidA in the membrane leads to the dissipation of the 240 
proton motive force (59) and to the activation of murein hydrolases like atl (40). As a pu-241 
tative antiholin, LrgA acts to inhibit the oligomerization of CidA. Therefore, the competi-242 
tion between CidA and LrgA is thought to modulate murein hydrolase activity, with the 243 
balance of CidA and LrgA determining the potential for the induction of PCD. 244 
In addition to modulation of cell death by the proposed holin-antiholin system the 245 
cidABC, lrgAB and alsSD operons influence cell death on a metabolic level, through cidC 246 
and alsSD. The cidC-encoded pyruvate oxidase (60) contributes to cell death during sta-247 
tionary phase by promoting the acidification of the growth media via the production of 248 
acetate (61). The membrane of the cell normally acts as a barrier to the negatively 249 
charged acetate in the media (61). If the pH of the environment drops and approaches the 250 
isoelectric point of acetate (~4.8) there is an increased percentage of acetate that is proto-251 
nated to acetic acid. The neutrally charged acetic acid can then freely diffuse across the 252 
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membrane into the bacterial cytoplasm. Once across the membrane the protons disassoci-253 
ate from acetic acid. 254 
It is not entirely understood how the influx of acetic acid can kill a bacterial cell. It 255 
has been proposed that the increase of intracellular weak acids decreases the cytoplasmic 256 
pH, which could lead to the misfolding or unfolding of proteins (61). This theory is sup-257 
ported by the fact that the clp genes, involved in protein folding and recycling, are up-258 
regulated when exposed to weak acids (62). It has also been proposed that the acetate re-259 
duces the functionality of the electron transport chain (61), potentially creating a bottle-260 
neck that leads to the formation of ROS. Of course, the mode of killing by acetate might 261 
also be a combination of both mechanisms. However, it is important to remember is that 262 
weak acid-induced cell death is an active process that requires the synthesis of RNA and 263 
proteins de novo. When rifampicin is added to growing cultures at day 1 of a 5-day sta-264 
tionary phase survival assay, no ROS is detected by HPF staining on day 3 (unpublished 265 
data). As rifampicin blocks mRNA transcription, these results suggest that the formation 266 
of ROS that is normally seen on day 3 during stationary phase was the result of freshly 267 
translated proteins. This would mean that the cell death exhibited by S. aureus under the-268 
se conditions (61) is an active process, not unlike the active process of apoptosis in eu-269 
karyotes. Interestingly enough, apoptosis features acidification of the cytoplasm (63).  270 
Thus, we hypothesize that the cid operon mediates cell death via a complex process in-271 
volving the metabolic potentiation of cell death, possibly mediated by the activation of a 272 
holin-like complex associated with the cytoplasmic membrane.  273 
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The alsSD operon encodes α-acetolactate synthase (alsS) and α-acetolactate decar-274 
boxylase (alsD) (61).  AlsSD creates acetoin (61, 64), which can be processed further by 275 
acetoin reductase (butA) to create 2,3-butanediol (56). The synthesis of acetoin and 2,3-276 
butanediol creates a more neutral intracellular pH by consuming pyruvate, redirecting 277 
carbon away from cidC. The formation of 2,3-butanediol also acts to replenish NAD
+
, 278 
allowing redox balancing of the cell. alsSD then promotes cell survival, acting as a coun-279 
terbalance to the cytoplasm acidification promoted by cidC (61).  Both cidC and alsSD 280 
consume the pyruvate created by glycolysis, acting as part of the carbon overflow mech-281 
anisms of the cell (61). Lending further support to the idea that cidABC and alsSD are 282 
acting in concert is the fact that both operons are under the control of the same transcrip-283 
tional regulator, CidR (61, 64, 65). 284 
 285 
Role of central metabolism in CidR-mediated regulation 286 
Because of the importance of excess glucose to cid-mediated cell death (64, 65) cen-287 
tral metabolism and carbon catabolite repression (CCR) probably play a central role in 288 
CidR-mediated regulation. In glycolysis, carbohydrates like glucose are catabolized to 289 
form pyruvate. For every molecule of glucose two ATP molecules are formed, as well as 290 
two pyruvate and two NADH molecules (66-68). In S. aureus the TCA cycle is repressed 291 
under nutrient rich conditions (69). Little carbon, in the form of acetyl-coA, enters the 292 
TCA cycle during nutrient rich growth (70, 71). Instead, carbon is redirected into carbon 293 
overflow pathways. When grown under aerobic conditions most of the carbon is directed 294 
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into acetate formation via the ackA-pta (72) and cidC pathways (60, 61), and into 295 
acetoin/2,3 butanediol via alsSD and butA (61).  296 
By 8 hours of growth in liquid culture the preferred carbon source is exhausted from 297 
the media, even with 35 mM glucose (72). S. aureus will then switch to the consumption 298 
of secondary metabolites to sustain growth, and begin consuming acetate, converting it 299 
back to acetyl-CoA by way of AcsA (73) and directing the carbon into the TCA cycle. 300 
This is accompanied by an increase in TCA cycle activity and a rapid change in the redox 301 
ratio, shifting the NADH/NAD
+
 ratio in favor of NADH. The oxidation of the influx of 302 
NADH requires oxidative phosphorylation via the electron transport chain.  303 
In Gram-positive bacteria like S. aureus, CCR is mediated by Hpr and CcpA (74, 75). 304 
The preferred carbon source of S. aureus is glucose which, like other sugars, enters the 305 
cell primarily through the phosphotransferase system (74, 76). During import into the cell 306 
the glucose is phosphorylated by the PTS to glucose 6-phosphate. As part of the first 307 
steps of glycolysis, glucose 6-phosphate is converted to fructose 1,6 bis-phosphate by 308 
glucose 6-phosphate isomerase (pgi) and 6-phophofructokinase (pfkA). High levels of 309 
fructose 1,6 bis-phophate lead to phosphorylation and activation of HprK kinase (77, 78), 310 
which in turn phosphorylates and activates Hpr (74). Fructose-1,6-bisphosphate and glu-311 
cose-6-phosphate promote the association of phosphorylated Hpr with CcpA (74).  The 312 
CcpA-Hpr regulates target genes by binding to CRE sites (67). The CRE site is typically 313 
found within the transcription initiation or promoter sequences when CcpA acts as a re-314 
pressor (74), and upstream of the promoter sequence when it acts as a positive regulator.  315 
 316 
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Effect of oxygen on cidABC and alsSD expression 317 
 Under anaerobic or hypoxic conditions the carbon consumed by S. aureus will be di-318 
rected towards lactate via Ldh (61, 79) rather than acetate or acetoin. Metabolically, the 319 
reason for redirection of carbon would appear to be redox balance. The formation of 2,3 320 
butanediol and lactate both consume NADH, which would be in excess because of its 321 
formation during glycolysis (67, 72). Although carbon is not being directed through the 322 
pathways of cid and als, these operons are, nonetheless, up-regulated under anaerobic and 323 
hypoxic conditions (31).  324 
Despite being a facultative anaerobe, the process by which S. aureus detects oxygen 325 
is poorly understood (80), as S. aureus does not possess homologues of the oxygen sens-326 
ing genes used by other species (81). S. aureus must have a means of sensing oxygen to 327 
properly determine the route to direct carbon, which would affect the transcription of 328 
cidABC and alsSD. It has been proposed that S. aureus detects oxygen via the SrrAB 329 
two-component system (81). SrrAB is a homologue of ResDE, known to be essential for 330 
anaerobic respiration in many Gram-positive bacteria (80). SrrAB also regulates viru-331 
lence factors (81, 82), genes involved in cytochrome synthesis and the electron transport 332 
chain (83) biofilm formation and protein synthesis (84) and the TCA cycle (67, 79). De-333 
spite being considered an oxygen sensor, the exact signal that SrrAB responds to is un-334 
known. Due to its ability to respond to nitric oxide stress and oxygen availability (81, 83) 335 
it has been proposed that SrrAB detects changes in the redox status of the electron 336 
transport chain by sensing reduced menaquinone, rather than oxygen per se. As of yet, 337 
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however, this has not been definitively proven. Regardless of the signal, SrrAB is essen-338 
tial for anaerobic growth and respiration (67, 80).  339 
 340 
CidR-mediated regulation of cidABC and alsSD transcription 341 
The cidABC and alsSD operons are positively regulated by CidR (64, 65), a member 342 
of the LysR-type transcriptional regulator family of proteins, or LTTRs (65). Formally 343 
discovered in 1988 (85), LTTRs currently represent the largest known family of tran-344 
scriptional regulators (86), with over 800 known members found in all domains of life 345 
(87). Few members of the family have been crystallized (88), but it is believed that mem-346 
bers of the LTTR family have a very conserved structure (88, 89), displaying strong ho-347 
mology in the helix-turn-helix DNA-binding domain of the N-terminus of these proteins 348 
(87). In contrast, the C-terminus of the LTTR has limited homology between members of 349 
the protein family (87, 90), likely reflecting the different molecules to which these pro-350 
teins interact. 351 
As a consequence of the highly conserved N-terminal helix-turn-helix DNA binding 352 
domain shared between LTTRs (87) there is a common DNA binding motif. The nucleo-353 
tide sequence of an LTTR binding site is typically characterized by a T-N11-A sequence 354 
motif (87). The N11 and surrounding bp, usually arranged within an inverted repeat, give 355 
the LTTR binding site its specificity for a specific LTTR protein, though crosstalk be-356 
tween LTTRs is not unknown (91-93). In genes that are positively regulated by an LTTR 357 
the binding site typically occurs within 100 bp upstream of the -35 element (87). Another 358 
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common feature of LTTR binding sites is that they are usually flanked by AT-rich re-359 
gions of DNA. AT-rich sections of DNA alter the DNA’s intrinsic curvature (87, 94, 95), 360 
which in turn facilitates LTTR regulation of its target promoter. The LTTR binding site 361 
itself contains two separate elements separated by a few bp, termed the Recognition 362 
Binding Site (RBS) and the Activation Binding Site (ABS). The LTTR binds each ele-363 
ment as a dimer, and the dimers interact to form a tetramer. It is the tetramer itself that 364 
acts to bend the DNA (87). The angle of the bend can vary widely depending on the 365 
LTTR, anywhere between 50 and 100 degrees (96). It is thought that the high angle of the 366 
bent DNA impedes formation of the RNA transcription bubble. In the presence of a sig-367 
nal, the co-inducer molecule, the LTTR undergoes a conformational change, causing the 368 
tetramer to shift on the DNA and relax the degree of the angle. The degree of relaxation 369 
is also dependent on the LTTR in question, which can decrease as much as 50 degrees 370 
(96).   The new angle then allows for the formation of an RNA transcription bubble, and 371 
facilitates transcription. This model of LTTR regulation has been termed the ‘sliding di-372 
mer’ model (97). 373 
The signal to which an LTTR responds, the co-inducer, is a small molecular weight 374 
compound, which is bound by the C-terminus (87). In LTTRs involved in the regulation 375 
of metabolism, the co-inducer is often a product of the genes that the LTTR regulates 376 
(87), creating a feedback loop. With CidR it was initially proposed that acetate, the prod-377 
uct of CidC could be the co-inducer molecule (98). This has not been confirmed, and fur-378 
thermore instances in which cidABC is induced without the presence of acetate have been 379 
found (31, 72, 98, 99). Since induction of cidABC and alsSD is studied in the context of 380 
excess glucose (64, 65), it would seem likely that the co-inducer molecule is a product of 381 
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central metabolism. Given that cidABC and alsSD play a role in carbon overflow metabo-382 
lism (61, 72) it has been proposed more recently that the co-inducer molecule is pyruvate 383 
(100), though this too has yet to be definitively confirmed.  384 
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Hypothesis and specific aims 385 
Hypothesis – The hypothesis for this dissertation is that the co-inducer of CidR is a 386 
metabolite from central metabolism. Given the complexity of central metabolism and the 387 
different factors involved, it was decided to approach this from several different avenues. .  388 
Aim 1: Mutagenize the cidABC and alsSD promoter regions to identify the CidR bind-389 
ing site.  390 
Aim 2: Employ transposon mutagenesis to identify metabolic pathways that effect the 391 
induction of cidABC transcription.  392 
Aim 3: Use DNA-protein interaction experiments to identify the CidR co-inducer.  393 
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Chapter II. Materials and methods 394 
Table 1 395 
Bacterial Strains  
Name Relevant characteristics Source 
S. aureus  
UAMS-1 Clinical osteomyelitis isolate, rsbU+ (101) 
JE2 derivative of LAC-13c; cured of cryptic 
plasmid 
(102) 
RN4220 Highly transformable strain; restriction defi-
cient 
(103) 
KB1058 UAMS-1 ∆cidC (61) 
KB1060 UAMS-1 ∆cidB, markerless (104) 
KB1064 UAMS-1 ∆lrgAB Lab stock 
KB1065 UAMS-1 ∆cidA∆2-52, markerless (104) 
KB1090 UAMS-1 cidR::Tet; Tet
r 
(65) 
KB5010 UAMS-1 ∆lytSR (105) 
KB6001 JE2 ∆geh::lacZ (104) 
KB6004 UAMS-1 ∆srrAB, markerless (106) 
16 
 
KB6005 UAMS-1 ∆srrAB ∆cidABC, markerless (104) 
KB6006 UAMS-1 ∆srrAB ∆cidA, markerless (104) 
KB6007 UAMS-1 ∆srrAB ∆cidB, markerless (104) 
KB6008 UAMS-1 ∆srrAB ∆cidC, markerless (104) 
 UAMS-1 ∆ccpA::tet; Tetr Lab stock 
KB8000 UAMS-1 ∆ackA::ermB; Ermr (72) 
 
E. coli  
DH5α Host strain for construction of recombinant 
plasmids 
(107) 
BL21  Expression strain, F-, ompT, hsdS (rB
-
mB
-
), 
gal, dcm (DE3) 
Invitrogen 
Rosetta 2 F
– 
ompT hsdSB (rB 
–
 mB 
–
) gal dcm pRARE2 
(Cam
R
) 
Invitrogen 
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Table 2: Plasmids 396 
Plasmids  
Name Relevant characteristics Source 
pAJ22  β-galactosidase  reporter plasmid; Camr (108) 
pBKalsSD pCR-Blunt derivative, contains promoter from 
pIHW24lac;  ColE1 oriV, kan
R
 
This study 
pBursa  bursa aurelis oriV Cam
r 
Erm
r
 (109) 
pCL52.2  Temperature-sensitive shuttle vector; Tet
r
 Sp
r 
(110) 
pCM12  E. coli/S. aureus shuttle vector with PsarA-
sodARBS-gfp (superfolder); Amp
r
 Sp
r 
(111) 
pCM28 Derivative of pDB59; Cam
r
 (112) 
pCM28-1544 pCM28 with cidABC reporter lacZ; Amp
r
 Cam
r
 This study 
pCN51 Pcad-inducible plasmid; Amp
r
 Erm
r 
(113) 
pCR-Blunt PCR cloning vector; ColE1 oriV, kan
R
 Invitrogen 
pET24b IPTG-inducible E. coli expression plasmid; kan
R
 Invitrogen 
pET24b-ccpA pET24b with gene encoding CcpA This study 
pET24b-cidR pET24b with gene encoding CidR This study 
pET24b-srrA pET24b with gene encoding SrrA (104) 
pFA545 mariner transposase (109) 
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pIHW5 Pcad-inducible lacZ reporter plasmid; Amp
r
 Erm
r
 (104) 
pIHW7 Promoterless lacZ reporter plasmid, derivative of 
pCN51; Amp
r
 Erm
r
 
(104) 
pIHW9 cidABC reporter plasmid; Amp
r
 Erm
r
, 658 bp This study 
pIHW10lac cidABC reporter plasmid; Amp
r
 Erm
r
, truncation -
177 upstream of transcription start site 
(104) 
pIHW11lac cidABC reporter plasmid; Amp
r
 Erm
r
, truncation -
138 upstream of transcription start site 
This study 
pIHW17lac cidABC reporter plasmid; Amp
r
 Erm
r
, truncation -
57 upstream of transcription start site 
This study 
pIHW22lac cidABC reporter plasmid; Amp
r
 Erm
r
, truncation -
93 upstream of transcription start site 
This study 
pIHW24lac alsSD reporter plasmid; Amp
r
 Erm
r
, truncation -
247 upstream of transcription start site 
This study 
pIHW25 UAMS-1 geh allellic exchange with PcidABC 
lacZ reporter (pCL52.2); Tet
r
 Sp
r 
this study 
pIHW26 pCR-Blunt derivative, contains cidABC promoter;  
ColE1 oriV, kan
R
 
This study 
pIHW32lac alsSD reporter plasmid; Amp
r
 Erm
r
, truncation -
116 upstream of transcription start site 
This study 
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pIHW33lac alsSD reporter plasmid; Amp
r
 Erm
r
, truncation -
47 upstream of transcription start site 
This study 
pIHW46 cidABC reporter plasmid; Amp
r
 Erm
r
, TAG-
TAATACAAA( -65 to -53)AAAAAAAAAAAA 
This study 
pIHW48 cidABC reporter plasmid; Amp
r
 Erm
r
, TAGT( -65 
to -61)AAAA 
This study 
pIHW49 cidABC reporter plasmid; Amp
r
 Erm
r
, TACA( -59 
to -55)AAAA 
This study 
pIHW58 srrAB complementation plasmid; Tet
r
 Sp
r 
(104) 
pIHW62 alsSD reporter plasmid; Amp
r
 Erm
r
, TAC(-49 to 
46)AAA 
This study 
pIHW63 alsSD reporter plasmid; Amp
r
 Erm
r
, TAGT(-55 to 
51)AAAA 
This study 
pIHW64 alsSD reporter plasmid; Amp
r
 Erm
r
, 
TAGTATTACAAA(-55 to 
43)AAAAAAAAAAAA 
This study 
pJB12 Temp
S
 UAMS-1 ∆cidB plasmid (pCL52.2) (104) 
pJB51 pCN51 with optimized RBS; Amp
r
 Erm
r 
(104) 
pJB60  Temp
S
 allellic exchange plasmid with counter-
selection; Amp
r 
Cam
r 
(104) 
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pJB60-114115 Temp
S
 UAMS-1 ∆cidABC plasmid; Ampr Camr (104) 
pJB61 Temp
S
 allellic exchange plasmid with counter-
selection; Amp
r 
Cam
r 
(104) 
pJB66 pJB51 with gfp gene from pCM12; Amp
r
 Erm
r 
(104) 
pJB67  pCN51 with optimized ribosome binding site; 
Amp
r
 Erm
r 
(104) 
pJB94 E. coli/S. aureus shuttle vector; Tet
r 
Sp
r 
(104) 
pJB97 UAMS-1 cidB complement plasmid; Amp
r
 Erm
r 
(104) 
pRN8298  pI258 replicon; Amp
r
 Erm
r 
(113) 
Antibiotic abbreviations  397 
Tet - tetracycline
 398 
Erm - erythromycin
 399 
Cam - chloramphenicol
 400 
Kan - kanamycin
 
401 
Sp - spectinomycin
 402 
Amp - ampicillin403 
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Table 3: Oligonucleotides 404 
Primers   
Name Sequence Source 
Buster  GCTTTTTCTAAATGTTTTTTAAGTAAATCA
AGT ACC  
(109) 
Martn-ermR  AAACTGATTTTTAGTAAACAGTTGAC 
GATATTC  
(109) 
RTPCR alsS F TTGGATGGCACGTAATTTCA (99) 
RTPCR alsS 
R 
GCCAGCAACGGATACAACTT (99) 
sigA-rt-F AACTGAATCCAAGTCATCTTAGTC (99) 
sigA-rt-R TCATCACCTTGTTCAATACGTTTG (99) 
cidA-rt-F GGGTAGAAGACGGTGCAAAC (99) 
cidA-rt-R TTTAGCGTAATTTCGGAAGCA (99) 
IW3 gcccgggATGACCATGATTACGGATTCACTG
GCCGTC 
(104) 
IW4 gggcgcgccTTATTTTTGACACCAGACCAACT
GGTAATGG 
(104) 
IW10  gggatccAGCAAATTATCAATGATGAAGTAG This study 
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ATATAGGC 
IW11 ggctagCGCCATCCCTTTCTAAATATGTCTAA
ATTGTTAC 
(104) 
IW16 ggatccCTTGGATCATTGAAATAATGAGTGT
TTTTTTTG  
This study 
IW22 ggatccCAAACCATAAAAAAAGAGTATTTTT
ATATTG 
This study 
IW27  gaattcTACATCCCTTGCTTATAGACACGATT
AGTAATC  
This study 
IW28  gagctcGAAAAACAACTGCACTTTCAATATA
ACATGACA  
This study 
IW29  ctgcagGTGCTACTAACATGGCACGGAAGAT
ATAAGTAG  
This study 
IW30  aagcttCAACCAACAAAAGGTGCCATTGTCT
ACATTCAT 
This study 
IW31 ggatccGAAATTTAGAGAGCGTTTCCATAGA
AAATAGTA  
This study 
IW39 gggatccTTTAAATCGCCAAAAACAGCATTTT
CAAAC  
This study 
IW41 ggctagcTTATATTCATTTCCCTTCAAATGTG
ATGTG 
This study 
23 
 
IW44 ctgcagTGTCACTTTGCTTGATATATGAGAAT
TATTTAA 
This study 
IW50  ggatccTCAATCCAACATCCCTTATAATCACT
CCCTTCA  
This study 
IW51 ggatccCAAATAACGATTTTTATTCATCTTAC
AAAGG 
This study 
IW52 cacctaggAATTGAATGAGACATGCTACACCT
CCGGATA  
This study 
IW91c gggaattcGAACAGCGTAGCCAACAATTAATT
ACTACTGA 
(104) 
IW92c ggggatccACATGCTTTTCTTTACAAAAGTAT
TATATCAC 
(104) 
IW93c ggggatccTAAAATTGAATATAGTTATTTCAG
AACGCATG 
(104) 
IW94c ggtctagaGTAATTGTCTTTAGTGCTAAATAA
AGTTGTAA 
(104) 
IW100 GACGCCTCATGAAGTAAAAGTGATGCGTC
A 
(104) 
IW101 ATAGTTGATATTCGCAAAAACCCTAAACC
C 
(104) 
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IW110  biotin- 
AGTGAAATTTAGAGAGCGTTTCCATAGAA
AATAGTAATACAAACCATAAAAAAAGAG
TAT 
This study 
IW111 AGTGAAATTTAGAGAGCGTTTCCATAGAA
AATAGTAATACAAACCATAAAAAAAGAG
TAT 
This study 
IW112 biotin- 
ATACTCTTTTTTTATGGTTTGTATTACTAT
TTTCTATGGAAACGCTCTCTAAATTTCACT 
This study 
IW113 ATACTCTTTTTTTATGGTTTGTATTACTAT
TTTCTATGGAAACGCTCTCTAAATTTCACT 
This study 
IW114  ggctagcTGATTGAAAGGTTATCACAATTGA
ATTGAA 
(104) 
IW115  ggggtcgacCCAGAACGGTGAATAGAAAATA
TGATGTAA 
(104) 
IW116c ggctagcGAGGAAATTATGACAGTTACTATA
TATGATGTAGC 
This study 
IW117cc ggctcgagTTTTGTAGTTCCTCGGTATTCAATT
CTGTGTGG   
This study 
IW118cc ggctagcGTGGGAGGTATGACCTGTATGTCG (104) 
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AACG 
IW119ccc gctcgagTTTAGCCGGCTCATCATTAGATTTA
ACCTCAAATTTATACC  
(104) 
IW128cc gggctagcGTGGATATCAAACATATGAAATAT
TTTATT 
This study 
IW129cc ggctcgagGCCTAAACGATCTTTCAAAAATTC
TATCCA  
This study 
IW130 GAGCATCGACTCGCAAAATA This study 
IW131c CAAAGCCAACGTTTTTAGCA This study 
IW132 CGGGTCAACAAATGGATTTAGATGAATTC
CAAGC 
This study 
IW133 CGCTCAACCTGGTCGAGCAAGTGGTTTTT
GTATATAC 
This study 
IW135 biotin- 
TCAAAATCTACTCATGCATTTTTGGAATA
CTTAGTATTACAAATAACGATTTTTATTCA
T 
This study 
IW136 ATGAATAAAAATCGTTATTTGTAATACTA
AGTATTCCAAAAATGCATGAGTAGATTTT
GA 
This study 
IW137  This study 
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TCAAAATCTACTCATGCATTTTTGGAATA
CTTAGTATTACAAATAACGATTTTTATTCA
T 
IW138 ggagctcACAATAACAGAAGGTCGTAATCGT
CAAGTC  
(104) 
IW139 gggatccTTATTCTGGTTTTGGTAGTTTAATA
ATAAA 
(104) 
IW141 /5phos/TTTTGGAATACTTAGTAATACAAAT
AACGATTTTT 
This study 
IW142 /5phos/ATGCATGAGTAGATTTTGAAGGGA
GTGATT  
This study 
IW145 GTGTCGCGTGTTGTTAATGG This study 
IW146 GTCCACGAGCAAGTTGTGAA This study 
IW147 ggggatccGTGGGAGGTATGACCTGTATGTCG
AACG 
(104) 
IW15 ggatccCATATTAATAAAGCACTCATTATTTG
TGATTCC  
(104) 
IW152 ggggtcgacTTTAGCCGGCTCATCATTAGATTT
AACCTCAAATTTATACC 
(104) 
IW154 GCTTATGAACTTGCAATGGAG (104) 
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IW155 CAGTTGATACTCATGTTAAACGAC (104) 
IW156 GGGCTCATCTCAAACATATATTTTG (104) 
IW157 CGGAAATGCGTGATTTAGAAATG (104) 
IW162 AGTGAAATTTAGAGAGCGTTTCCATAGAA
AACATATTAATAAACCATAAAAAAAGAG
TAT 
This study 
IW163 ATACTCTTTTTTTATGGTTTATTAATATGT
TTTCTATGGAAACGCTCTCTAAATTTCACT 
This study 
IW166 TCAAAATCTACTCATGCATTTTTGGAATA
CTTAGTATTACAAATAACGATTTTTATTCA
T 
This study 
IW167 ATGAATAAAAATCGTTATTTGTAATACTA
AGTATTCCAAAAATGCATGAGTAGATTTT
GA 
This study 
IW168 biotin- 
ATAGTTATTGTAACAATTTAGACATATTT
AGAAAGGGATGGCGCCATGCACAAAGTC
CAA 
(104) 
IW169 TTGGACTTTGTGCATGGCGCCATCCCTTTC
TAAATATGTCTAAATTGTTACAATAACTA
T 
(104) 
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IW170 ATAGTTATTGTAACAATTTAGACATATTT
AGAAAGGGATGGCGCCATGCACAAAGTC
CAA 
(104) 
IW170 ATAGTTATTGTAACAATTTAGACATATTT
AGAAAGGGATGGCGCCATGCACAAAGTC
CAA 
This study 
IW171 /5phos/TTTTGGAATACTTAGTATTAAAAAT
AACGATTTTT 
This study 
IW172 /5phos/TTTTGGAATACTAAAAATTACAAAT
AACGATTTTT 
This study 
IW173 /5phos/TTTTGGAATACTAAAAAAAAAAAA
TAACGATTTTT 
This study 
IW174 biotin- 
TTTAAATCGCCAAAAACAGCATTTTCAAA
C 
This study 
IW175 biotin- 
CATAGAAAAAAAAAATACAAACCATAAA
AAAAGAGTATTT 
This study 
IW176  CATAGAAAAaaaaAATACAAACCATAAAAA
AAGAGTATTT 
This study 
IW177  AAATACTCTTTTTTTATGGTTTGTATTTTTT This study 
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TTTTCTAT 
IW178 biotin- 
CATATTAATAAAGCACTCATTATTTGTGA
TTCCTCATTACTTGGATCATTGAAATAATG
A 
This study 
IW179 CATATTAATAAAGCACTCATTATTTGTGA
TTCCTCATTACTTGGATCATTGAAATAATG
A 
This study 
IW180 TCATTATTTCAATGATCCAAGTAATGAGG
AATCACAAATAATGAGTGCTTTATTAATA
TG 
This study 
IW181 Biotin- 
AAAAAGAGTATTTTTATATTGTGTACGCC
ATCTTTATAATAGTTATTGTAACAATTTAG
A 
This study 
IW182 AAAAAGAGTATTTTTATATTGTGTACGCC
ATCTTTATAATAGTTATTGTAACAATTTAG
A 
This study 
IW183 TCTAAATTGTTACAATAACTATTATAAAG
ATGGCGTACACAATATAAAAATACTCTTT
TT 
This study 
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IW184 /5phos/TTTTGGAATACTTAGTATAAAAAAT
AACGATTTTT 
This study 
IW193 gggagctcACATTTTTCAACAAATGCAATTGA
TATTTG 
This study 
IW194 ggggatccTTATTTTGTAGTTCCTCGGTATTCA
ATTCT 
This study 
JBCACOMP1 cggatCCGCATGCAAATTATCAATGATGAAG
TAGATATAGGC 
(104) 
JBCDALAC3 cgtcgacCCATGCTTGTAATGCTTTAACTAAT
GCTTC 
(104) 
JBGFP4 cgaattcttaTTTGTAGAGCTCATCCATGCCATG
TG 
(104) 
JBGFP8 CCATATGCCCGGGagcaaaggagaagaacttttcactgg  (104) 
JBI258ORI1  ccagatctggcgaatggcgccgttttatcttcatcac (104) 
JBI258ORI2 GGTGTACAGGGCCCTCGATGATTACCAGA
AGTTCTCAC 
(104) 
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Bacterial strains and growth conditions 405 
All the bacterial strains used in this study are listed in Table 1. S. aureus strains were 406 
grown in tryptic soy broth (TSB; Difco Laboratories, Detroit, MI) or filter-sterilized NZY 407 
broth (3% [wt/vol] N-Z Amine A [Sigma Chemical Co., St. Louis, Mo.], 1% [wt/vol] 408 
yeast extract [Fisher Scientific, Fair Lawn, N.J.] adjusted to pH 7.5). Escherichia coli 409 
DH5α was grown in Luria-Bertani medium (Fisher Scientific). Liquid S. aureus cultures 410 
were grown in Erlenmeyer flasks at 37°C with shaking (250 rpm) in a volume that was 411 
no greater than 10% of the flask volume. Hypoxic conditions were performed using the 412 
same media in 3:5 media volume to flask ratio with shaking at 60 rpm. All antibiotics 413 
were purchased from either Sigma Chemical Co. or Fisher Scientific and were used at the 414 
following concentrations: kanamycin, 50 µg · ml
-1
; chloramphenical, 10 µg · ml
-1
; ampi-415 
cillin, 100 µg · ml
-1
; and erythromycin, 5 µg · ml
-1
. 416 
 417 
DNA manipulations  418 
Genomic DNA was isolated from S. aureus using the Wizard Plus kits from Promega, 419 
Inc. (Madison, Wis.). Restriction endonucleases, DNA polymerases and T4 DNA ligase 420 
used in this study were purchased from either New England Biolabs (Beverly, Mass.) or 421 
Invitrogen Life Technologies (Carlsbad, Calif.). Recombinant plasmids were isolated us-422 
ing the Wizard Plus SV Minipreps DNA purification system (Promega Corporation, 423 
Madison, WI). PCR was performed using primers purchased either from Integrated DNA 424 
Technologies (Coralville, IA) or Eurofins Operon (Louisville, KY), a KOD polymerase 425 
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kit (Novagen, Madison, WI), and an Applied Biosystems GeneAmp PCR System 9700 426 
(Life Technologies Corporation, Carlsbad, CA). DNA fragments were recovered using 427 
the DNA Clean and Concentrator-5 Kit (Zymo Research, Orange, CA) and recombinant 428 
DNA plasmid products were sequenced at the University of Nebraska Medical Center 429 
DNA Sequencing Core facility and analyzed using Vector NTI (Invitrogen, Carlsbad, 430 
CA). 431 
The lacZ reporter plasmid to monitor cidABC expression was created by first PCR 432 
amplifying the gfp gene of pCM12 (111) using primers JBGFP4 and JBGFP8. The result-433 
ing PCR was cloned into the NdeI and EcoRI sites of pJB51, a derivative of pCN51 con-434 
taining an optimized RBS, to yield the plasmid pJB66. An internal EcoRI digest was per-435 
formed which removed the gfp gene, leaving the desired construct pJB67. The lacZ gene 436 
in pAJ22 (108) was amplified by PCR using the primers, IW3 and IW4, and cloned into 437 
the SmaI and AscI restriction sites of pJB67 to produce the plasmid pIHW5. The cadmi-438 
um inducible promoter of pIHW5 was removed by digestion with SphI and PstI, treat-439 
ment with Klenow and self-ligated to produce the lacZ vector plasmid pIHW7. The 440 
cidABC promoter was PCR amplified off of the UAMS-1 genome using the primers, 441 
IW11 and IW15, and cloned into the BamHI and NheI cut sites to yield the final reporter 442 
product pIHW10lac. The alsSD reporter pIHW24lac was constructed by using the 443 
pIHW7 plasmid backbone. The primers IW39 and IW41 were used to clone the alsSD 444 
promoter fragment, which was then cloned into the BamHI and NheI cut sites to yield the 445 
reporter.  446 
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A nested set of DNA fragments spanning the cidABC promoter region was generated 447 
by PCR using a series of primer pairs that generated successively shortened fragments at 448 
the 5’ end but common 3’ ends. The 3’ primer used (IW11) generated a BamHI recogni-449 
tion site, while the 5’ primers (IW15, IW16, IW31 and IW22; see Table X) generated 450 
NheI recognition sites. Each PCR promoter fragment generated was digested with BamHI 451 
and NheI and cloned into pIHW4 or pIHW7, yielding the plasmids pIHW10(lac), 452 
pIHW11(lac), pIHW22(lac) and pIHW17(lac), respectively. A similar process was used 453 
to generate nested deletions in the alsSD promoter region. The primer, IW41, determined 454 
the 3’ end of the alsSD promoter fragment and was used in conjunction with the primers, 455 
IW39, IW50 and IW51, to generate the different 5’ ends. As above, the PCR products 456 
generated were digested with BamHI and NheI and ligated into pIHW4 or pIHW7 to pro-457 
duce the plasmids, pIHW24(lac), pIHW32(lac) and pIHW33(lac), respectively. All of the 458 
deletion constructs truncations were generated such that the -35 and -10 elements, as well 459 
as the untranslated regions (UTRs) of the cidABC and alsSD transcripts remained intact.   460 
Point mutations in the cidABC promoter region were generated following the protocol 461 
described by Bose et al. (40). The template used for these experiments was pIHW26, a 462 
derivative of the pCRblunt plasmid from the Zero Blunt PCR Cloning Kit (Invitrogen, 463 
Carlsbad, CA) containing the cidABC promoter. PCR products were self-ligated and then 464 
treated with DpnI to remove any methylated template DNA that remained. After diges-465 
tion, the DNA was transformed into DH5α, and kanamycin-resistant colonies were 466 
minipreped and potential plasmids screened by digest and sequenced. Plasmids contain-467 
ing the desired point mutations were digested with BamHI and NheI, and the promoter 468 
fragment cloned into pIHW7 (Table 1). The same strategy was used to construct point 469 
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mutations in the alsSD promoter using the template plasmid pBKalsSD, also a derivative 470 
of pCRblunt. 471 
Chromosome mutants were generated as previously described (40). Briefly, an in-472 
frame deletion plasmid for cidB was generated by amplifying approximately 1,000 bp of 473 
DNA flanking the cidB gene from the UAMS-1 chromosome. Subsequent cloning of the 474 
PCR products into pCL52.2 (110) yielded a plasmid, pJB12, which contains cidB gene 475 
replaced by an XhoI site. A similar strategy was used for cidA. Due to the presence of a 476 
cidBC promoter in the cidA open reading frame, an in-frame deletion of cidA was con-477 
structed such that the 5’ 150 bp (38%) of the cidA gene was removed, but leaving the 478 
cidBC promoter intact. This construct would produce a CidA protein lacking the first 50 479 
amino acids after the start codon. The cidC mutant was published previously (60). The 480 
srrAB knockout strain was constructed as described previously (106). To create a 481 
markerless cidABC knockout strain, UAMS-1 genomic DNA was used as a template for 482 
PCR using the primers, IW114 and IW115 (Table 1), to isolate the 3’ region of the 483 
cidABC operon. The PCR products were digested with SalI and NheI and ligated into the 484 
vector, pJB60, to produce the cidABC knockout plasmid, pJB60-114115. Deletion of the 485 
cidABC operon in UAMS-1 was then generated by allelic replacement as described pre-486 
viously (114).  487 
A srrAB complementation plasmid was generated by PCR amplifying the low-copy, 488 
pI258 replicon from pRN8298 (115) using the primers, JBI258ORI1 and JBI258ORI2. 489 
The PCR product was then ligated into the BglII and BsrGI sites of pCL52.2 (116), re-490 
placing the temperature-sensitive origin of replication to create the plasmid, pJB94. The 491 
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primers, IW138 and IW139, were used to amplify the srrAB operon, including its pro-492 
moter region, using UAMS-1 genomic DNA as a template. The PCR product was then 493 
ligated into the SmaI site of pJB94 in a blunt-end ligation reaction. The resulting plasmid, 494 
pIHW58, was confirmed to contain the proper DNA insert by DNA sequencing. A cidB 495 
complement plasmid was generated by PCR amplifying cidB from the UAMS-1 chromo-496 
some using the primers JBCACOMP1 and JBCDALAC3. The PCR product was digested 497 
with SphI and ligated into the same site of pCN51 to produce the plasmid pJB97. 498 
To create a markerless cidABC knockout strain the UAMS-1 genome was used as a 499 
template for PCR using the primers IW114 and IW115 to isolate the 3’ region after 500 
cidABC. The PCR was digested with SalI and NheI and cloned into the vector pJB60 to 501 
produce the cidABC knockout plasmid pJB60-114115. Deletion of the cidABC operon in 502 
UAMS-1 was then generated by allelic replacement as described previously (114). 503 
For easy use of a cidABC reporter in the Nebraska Transposon library mutants a new 504 
reporter plasmid had to be created as the erm resistant of the pIHW6 or 9 plasmids was 505 
incompatible with the transposon mutants. PCR of the cidABC promoter and lacZ was 506 
performed off of pIHW9 using the primers IW15 and IW44. The PCR product was di-507 
gested with BamHI and PstI and cloned into pCM28 to yield pCM28-1544, which was 508 
then used in all NE Transposon Mutants that were tested. 509 
 510 
Transposon mutagenesis  511 
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It was decided to integrate the reporter into the geh gene so that integration could be 512 
confirmed by lipase activity assays. Primers IW27 and IW28 were used to clone the 5’ 513 
region upstream of geh. The PCR products were digested with the restriction enzymes 514 
EcoRI and SacI and ligated into the plasmid pCL52.2 to produce the plasmid pIHW20. 515 
Primers IW29 and IW30 were used to clone the 3’ region downstream of geh. The PCR 516 
product was digested with the enzymes PstI and NheI and ligated into pIHW20 to pro-517 
duce the plasmid pIHW21. Finally, primers IW10 and IW44 were used to clone the 518 
cidABC promoter, lacZ reporter and blazTT off of pIHW9. The PCR product was then 519 
digested with PstI and BamHI and ligated into pIHW21 to produce the integration plas-520 
mid pIHW25.  521 
The reporter strain was made by first streaking out UAMS-1 containing the plasmid 522 
pIHW25 onto TSA + 10 µM · ml
-1
 tetracycline. The plate was then grown at 45°C over-523 
night. The plate was then restruck and grown at 45°C overnight again. Colonies were 524 
picked and used to inoculate 5 mL of TSB. Cultures were then grown at 30°C 250 rpm 525 
overnight. Cultures were diluted 1 to 1000 into fresh TSB daily for 3 days. Beginning the 526 
fourth day dilution plating was also performed. Colonies from the dilution plating were 527 
patched onto TSA and TSA + tet, both containing 35 mM glucose and 50 µg · ml
-1
 X-gal. 528 
Colonies that turned blue and were tetracycline sensitive were confirmed by PCR to have 529 
integrated properly to produce the strain KB6001. 530 
The mariner-based transposon (Tn) bursa aurealis was used to generate random Tn 531 
insertion mutations in S. aureus strain JE2 essentially as described by Bae et al. (109). 532 
First, bacteriophage φ11 was used to transduce the bursa aurealis delivery plasmid 533 
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pBursa into JE2 containing the transposase-encoding plasmid pFA545, with selection on 534 
TSA medium containing chloramphenicol (Cam) (10 µg · ml
-1
) and Tet (5 µg · ml
-1
). Af-535 
ter growth for 48 h at 30°C to allow for transposition events, one colony was resuspended 536 
in 100 µl of prewarmed 45°C water and then plated onto TSA plates containing erythro-537 
mycin (Erm) (25 µg · ml
-1
) and grown at 45°C for 12 to 24 h. Resulting colonies, irre-538 
spective of colony size, were then screened for loss of the temperature-sensitive plasmids 539 
pBursa and pFA545 by patching them on TSA-Erm (25 µg · ml
-1
), TSA-Cm (10 µg · ml
-540 
1
), and TSA-Tet (5 µg · ml
-1
). Those colonies that were Cm and Tet susceptible but re-541 
sistant to Erm were grown in 5 mL of TSB-Erm (5 µg · ml
-1
) and grown at 37°C over-542 
night.  543 
After overnight growth, the Wizard genomic DNA purification kit (Promega) was 544 
used to isolate genomic DNA from the cultures with the following modifications. Briefly, 545 
after centrifugation at 4,100 rpm for 5 min in a Sorvall (Newtown, CT) Legend tabletop 546 
centrifuge, supernatants were removed, the content of each well was resuspended in 110 547 
µl of 50 mM EDTA (pH 8.0), and 5 µl of 10-mg/ml lysostaphin was added. After incuba-548 
tion at 37°C for 60 min, 600 µl of Nuclei Lysis solution was added and the genomic 549 
DNA was collected according to the manufacturer’s instructions. After resuspension in 550 
Tris-EDTA (TE) buffer, the genomic DNA was digested with 10 units of AciI (New Eng-551 
land Biolabs) at 37°C for 4 h. AciI was then heat inactivated at 65°C for 30 min; T4 DNA 552 
ligase (200 U) (Monserate Biotechnologies, San Diego, CA) was then added to each 553 
sample and ligated overnight at 4°C, followed by heat inactivation at 65°C for 30 min. 554 
DNA fragments spanning the bursa aurealis insertion sites in each sample were ampli-555 
fied using the Buster (5= GCTTTTTCTAAATGTTTTTTAAGTAAATCAAGT ACC 3=) 556 
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and Martn-ermR (5= AAACTGATTTTTAGTAAACAGTTGAC GATATTC 3=) primer 557 
set. PCR conditions included 30 cycles with an annealing temperature of 63°C and an 558 
extension time of 3 min. Once amplified, samples of the DNA products were separated in 559 
a 1% agarose gel by electrophoresis, and the remainder was purified for sequencing using 560 
Exo-SAP-IT (GE Healthcare) according to the manufacturer’s instructions. Finally, de-561 
termination of the nucleotide sequences of the genomic DNA flanking the transposons 562 
was achieved using the Buster primer at the DNA Microarray and Sequencing Core Fa-563 
cility at the University of Nebraska Medical Center. 564 
 565 
 β-galactosidase assays 566 
 β-galactosidase assays were performed based on protocols previously described 567 
(105). Briefly, 1.0 ml of cell cultures was centrifuged and the cell pellet was resuspended 568 
in 1 ml Z-buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 50 569 
mM β-mercaptoethanol, pH 7.0) and disrupted using a FastPrep FP120 (MP Biomedicals, 570 
Santa Ana, California). Cellular debris was pelleted by centrifugation and 700 μl of the 571 
supernatant was transferred to a 1.5 ml microcentrifuge tube. After the addition of 140 μl 572 
of ONPG (4 mg ml
-1
), the samples were incubated at 37°C until they turned slightly yel-573 
low (under OD420 1.0). To stop the reactions, 500 μl of 1 M sodium carbonate was added 574 
and the OD420 was measured. Protein concentrations were determined by performing 575 
Bradford Assays using the Protein Assay Dye Solution (Bio-Rad, Hercules, California). 576 
Miller units were calculated using protein concentration instead of OD600 (117). 577 
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Expression of recombinant protein  578 
To produce purified CidR for analysis, the cidR gene was PCR-amplified using the 579 
primers, IW128cc and IW129cc, and UAMS-1 genomic DNA as a template. The PCR 580 
product was ligated into the NheI and XhoI sites of pET24b and the DNA sequence con-581 
firmed by sequencing the cloned product. The resulting plasmid (pET24b-cidR) was 582 
transformed into the rare-codon enhanced E. coli strain BL21 derivative Rosetta 2 583 
(Novagen, Madison, WI) for protein expression. For CcpA, the ccpA gene was isolated 584 
from the UAMS-1 genome via PCR using the primers, IW116 and IW117, and ligated 585 
into pET24b as above. The resulting plasmid (pET24b-ccpA) was transformed into the E. 586 
coli strain BL21 (Novagen, Madison, WI) for expression. To produce purified SrrA for 587 
analysis, the srrA gene was PCR-amplified using the primers, IW147 and IW152, and 588 
UAMS-1 genomic DNA as a template. The PCR product was ligated into the NheI and 589 
XhoI sites of pET24b and the DNA sequence confirmed by sequencing the cloned prod-590 
uct. The resulting plasmid (pET24b-srrA) was transformed into BL21 (Novagen, Madi-591 
son, WI) for protein expression.  592 
To purify CidR, the Rosetta 2 (pET24b-cidR) strain was grown in 1 L of LB media 593 
containing kanamycin and chloramphenicol at 37°C until the culture reached mid-594 
exponential phase. IPTG was added to a final concentration of 0.4 mM to induce expres-595 
sion of CidR. The culture was transferred to a 20°C incubator and grown overnight. To 596 
purify CcpA, a similar approach was utilized, with the exception that the overnight cul-597 
tures were grown at 30°C. To express and purify SrrA, the BL21(pET24b-srrA) strain 598 
was grown in 1 L of LB media containing kanamycin at 37°C until the culture reached 599 
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mid-exponential phase. IPTG was added to a final concentration of 0.4 mM and srrA was 600 
expressed at 30°C overnight. The cells of all cultures were collected by centrifugation 601 
and resuspended in 50 mL lysis buffer (100 mM phosphate, 300 mM NaCl) containing 602 
PMSF (1.0 mM) to inhibit protease activity. Cells were lysed via serial passage through 603 
an Emulsiflex-C3. The proteins were then purified using HisPur™ Cobalt Purification 604 
Kit columns (Pierce Biotechnology, Rockford, IL) according to the manufacturer’s in-605 
structions. The proteins were then desalted via ultrafiltration using an exchange buffer 606 
(100 mM Tris-HCl, pH 8.0, 150 mM KCl, 1 mM EDTA, and 0.1 mM dithiothreitol). The 607 
purified protein was stored at -20°C in the exchange buffer containing 40% glycerol.  608 
 609 
Protein-DNA interactions  610 
The binding of purified proteins to target DNA was demonstrated by electrophoretic 611 
mobility shift assays (EMSAs) using a Lightshift Chemiluminescent Kit (Pierce Biotech-612 
nology, Rockford, IL) according to the manufacturer’s instructions. The target DNA used 613 
for the CidR and CcpA EMSAs were made by annealing 60 bp primers, IW110 and 614 
IW113 for cidABC, and IW135 and IW136 for alsSD, together. Mutant specific competi-615 
tor DNA was made from primers, IW162 and IW163 for the 4 bp mutation promoter, and 616 
primers IW176 and IW177 for the complete replacement of the CidR binding site. The 617 
target DNA used for the SrrA EMSAs were made by annealing the 60-bp primers, IW168 618 
and IW169. The binding reaction mixture for each sample contained 10 mM Tris, pH 7.5, 619 
50 mM KCl, 1 mM DTT, 2.5% glycerol, 1 µg of salmon sperm DNA, 5 mM MgCl2, 0.05% 620 
NP-40, 10 mM EDTA and 5 fmol of labeled DNA in a total volume of 20 µL. Competitor 621 
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DNA was added in 200-fold excess according to the manufacturer’s instructions. After 30 622 
minutes incubation at room temperature, the protein-DNA mixtures were separated in a 6% 623 
TBE gel in 0.5 TBE buffer at 85 volts. The DNA was then transferred from the gel to a 624 
nylon membrane and cross-linked to the nylon membrane using a UV Stratalinker® 1800 625 
(Stratagene ®) cross-linker instrument. The labeled DNA fragments were then imaged 626 
using an SRX-101a Imager (Konica Minolta, Wayne, NJ). 627 
 628 
Quantification of the mRNA transcripts 629 
 RNA isolation was carried out as described previously (118). Quantitative real-time 630 
PCR was performed using the sigA-, cidA- and alsS-specific primers listed in Table 3. 631 
Total RNA (500 ng) was converted to cDNA using the Quantitect Reverse Transcription 632 
Kit (Qiagen). The samples were then diluted 1:50, and the cDNA products were ampli-633 
fied using the LightCycler DNA Master SYBR green I kit (Roche Applied Science) fol-634 
lowing the manufacturer’s protocol. The relative transcript levels were calculated using 635 
the comparative threshold cycle (CT) method (119) with normalization to the amount of 636 
sigA transcripts present in the RNA samples.  637 
 638 
Flow cytometry 639 
Flow cytometry was performed as previously described (61). Briefly, a BD LSRII 640 
flow cytometer (Beckton and Dickinson, San Jose, California) was used to perform anal-641 
42 
 
yses using 1- and 3-day old stationary phase cultures of S. aureus. Cell samples were 642 
washed twice and diluted to a final concentration of 10
7
 cells per ml in PBS and then 643 
stained for 30 min with 5-cyano-2,3-ditolyl tetrazolium chloride (CTC, 5 mM) and 3-(p-644 
hydroxyphenyl) fluorescein (HPF, 15 mM). FACS analyses were performed at a flow rate 645 
of 1,000 cells per second. A total of 10,000 events were collected for each sample. Bacte-646 
ria were discriminated from background using a combination of forward scattered light 647 
(FSC) and side scattered light (SSC). Samples were excited at 488 nm using an argon la-648 
ser and HPF emission was detected at 530 + 30 nm (with a 505 nm long-pass mirror) 649 
whereas CTC emission was detected at 695 + 40 nm (with a 685 nm long-pass mirror). 650 
Raw data were analyzed using FlowJo software. 651 
 652 
Metabolite analyses 653 
For these analyses, bacterial growth was allowed to proceed at 37°C and 250 rpm in 654 
flasks containing TSB (35 mM glucose) in a 1:10 flask to volume ratio. Metabolite excre-655 
tion profiles were determined from culture supernatants that were harvested at 1 and 3 656 
days of incubation. Acetate was measured using commercial kits (R-Biopharm, Marshall, 657 
MI), according to the manufacturer’s instructions.  658 
Acetoin assays were performed as previously described (120). Briefly, Acetoin assay 659 
was performed as follows. 200 µL of supernatant was mixed with 140 µL 0.5% creatine, 660 
200 µL 5% α-napthol, and 200 µL 40% KOH. The sample was incubated for 15 to 30 661 
minutes. The OD560 was measured and used to determine the concentration of acetoin.  662 
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Chapter III. A direct link between glycolysis and cid-mediated Staphylococcus 663 
aureus cell death 664 
Introduction 665 
Many Staphylococcus aureus infections are thought to involve biofilms, a structured 666 
community of bacteria held together by an extracellular matrix created by the bacterial 667 
population (28). The composition of this matrix is diverse in nature and critical for adher-668 
ence between cells and adherence to surfaces (34). Many different molecules are part of 669 
the matrix, including carbohydrates, proteins, and extracellular DNA (eDNA). In S. 670 
aureus, it has been demonstrated that eDNA is an important component, released by the 671 
lysis of a subpopulation of cells in the biofilm via a process termed bacterial programmed 672 
cell death (PCD) (32, 121). The surviving cells benefit from the death of the subpopula-673 
tion by using the eDNA as part of the scaffolding of the matrix. 674 
Although the mechanism(s) controlling cell death are not fully understood, this pro-675 
cess is known to involve the products of the cidABC, lrgAB and alsSD operons (42, 61, 676 
64). In the past we have demonstrated that disruption of the cidA gene resulted in de-677 
creased antibiotic-induced death and lysis (50), whereas disruption of the lrgAB operon 678 
had the opposite effect (52). Additionally, CidA and LrgA were found to share sequence 679 
similarities with bacteriophage holins (50), proteins well-known for their role in the con-680 
trol of death and lysis. Based on these findings a model was proposed in which CidA and 681 
LrgA represent a bacterial holin-antiholin system that is the foundation of bacterial PCD 682 
(42). CidA oligomerizes and forms pores in the cytoplasmic membrane, leading to mem-683 
brane depolarization, activation of murein hydrolase activity, and cell lysis (56). LrgA is 684 
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envisioned as an antiholin (52), opposing the activity of CidA by interfering with its abil-685 
ity to depolarize the membrane and cause subsequent death and lysis (50). More recently 686 
other effectors of cell death have been discovered. The cidC-encoded pyruvate oxidase 687 
(60) was shown to potentiate cell death during stationary phase and biofilm development 688 
by promoting cytoplasmic acidification through the production of acetate (61). At the 689 
same time the alsSD operon encodes α-acetolactate synthase (alsS) and α-acetolactate 690 
decarboxylase (alsD) which synthesize acetoin which has been found to have a role in 691 
promoting cell survival (61, 64). Though it might at first appear that cidC and alsSD have 692 
opposing functions, both operons consume the pyruvate created by glycolysis. It there-693 
fore seems likely that cidC and alsSD act as part of the carbon overflow mechanisms of 694 
the cell (61, 100). 695 
The regulation of cidABC and alsSD expression is known to be mediated by CidR (61, 696 
64, 65), which is required for the induction of transcription during growth in excess glu-697 
cose (50). CidR is a member of the LysR type transcriptional regulator (LTTR) family of 698 
proteins (65), which have a common mechanism of regulation and key motifs that appear 699 
in their target sequence. While we know that CidR-mediated regulation responds to ex-700 
cess glucose (64, 65) and low oxygen (99) we do not know the sequence of the CidR 701 
binding site.  702 
In the current chapter, we sought to better define the mechanisms of the regulation of 703 
cell death in S. aureus. We used genetic techniques to create truncations and mutations in 704 
the cidABC and alsSD promoters to ultimately define the sequence of the CidR binding 705 
site, 5’-TAGTA-A/T-TACAAA-3’. While creating our truncations we found that another 706 
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transcriptional regulator, CcpA, plays a direct role in the regulation of cidABC and alsSD, 707 
demonstrating a role for CCR in cidABC and alsSD induction that was not previously an-708 
ticipated. To uncovered further metabolic modulators of cidABC induction we also per-709 
formed Transposon Mutagenesis (Tn). EMSAs confirmed the regulation to be direct. The 710 
data we present here sheds light on the complicated regulation of cid and als, creating a 711 
more complete picture of PCD in S. aureus.  712 
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Results  713 
Identification of cis-acting elements important for CidR-inducible gene expression  714 
In a first step to defining the regulatory interactions associated with CidR-mediated 715 
regulatory control, we sought to identify the cis-acting DNA sequences important for 716 
binding of CidR to the promoter regions of the only two known targets of CidR regula-717 
tion, the cidABC and alsSD operons. Although LTTR binding sites typically encompass 718 
the consensus sequence T-N11-A (87), the AT-rich nature of S. aureus DNA made the 719 
identification of putative CidR-binding sites within the cidABC and alsSD promoter re-720 
gions difficult. We therefore constructed a nested set of truncations (Fig. 3.1) of the se-721 
quences spanning both promoter regions, fused them to the lacZ reporter gene, and intro-722 
duced these reporter plasmids into the S. aureus wild-type strain, UAMS-1. As both 723 
cidABC and alsSD transcription has been shown to exhibit CidR-dependent glucose-724 
inducible expression (51, 64), we grew each reporter strain in the presence of 35 mM 725 
glucose and measured β-galactosidase activity after six hours of growth. Consistent with 726 
previous results (65), glucose-inducible expression of both full-length cidABC and alsSD 727 
reporter constructs was shown to be abolished in the cidR mutant strain (data not shown), 728 
indicating that the cis-acting elements important for CidR-mediated control were intact. 729 
As can be seen in Fig. 3.2, removal of the regions 5’ to the nts -177, -138, and -93 up-730 
stream of the transcription start site had a minimal effect on cidABC-inducible expression, 731 
indicating the absence of elements important for glucose-inducible expression. In contrast, 732 
the -57 construct abolished induction, suggesting that a cis-acting element was present 733 
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 734 
Figure 3.1: Truncations of the cidABC and alsSD promoters. Truncations created for lacZ reporter 735 
plasmids in the A. cidABC and B. alsSD promoters. Truncations are denoted by numbers indicating bp be-736 
fore the transcription start site. All resulting reporter plasmids contain the native -35, -10 and transcription 737 
start site elements.  738 
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between nts -93 and -57. Analysis of the alsSD reporter constructs revealed that the re-739 
moval of the regions 5’ of nt -116 had little effect on glucose-inducible expression. How-740 
ever, the elimination of sequences 5’ of nt -47 resulted in a dramatic reduction in glucose-741 
inducible expression, indicating the presence of an important cis-acting regulatory ele-742 
ment between nts -116 and -47. Inspection of the DNA sequence of both promoters in 743 
this region revealed almost identical 12-bp elements, 5’-TAGTA-A/T-TACAAA-3’, be-744 
tween the two promoter regions. Interestingly, this sequence was in roughly the same re-745 
gion relative to the cidABC and alsSD transcription start sites identified previously  (50). 746 
This conserved element identified is one bp short of the consensus LTTR binding site. 747 
To specifically test the importance of these potential cis-acting elements, we generat-748 
ed mutations in both the cidABC and alsSD promoter reporter plasmids that altered the 749 
sequences of these elements. For example, mutations were generated that replaced 4 bp 750 
of the 5’ half site with AAAA, changed the only non-adenine bp in the 3’ half site to ade-751 
nine, and replaced the elements entirely. The reporters were then assessed for CidR-752 
dependent promoter activity as performed above. We found that all the mutations gener-753 
ated in both the cidABC (Fig. 3.3A) and alsSD (Fig. 3.3B) promoter regions eliminated 754 
expression, confirming their role in the induction of transcription of these operons.  755 
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 756 
Figure 3.2: Deletion analysis of the cidABC and alsSD promoters. Truncations made in the cidABC 757 
(A) and alsSD (B) promoters and the effect on induction. Cultures were grown in flasks containing NZY + 758 
35 mM glucose at a 1:10 media to volume ratio. After six hours of growth samples of the cultures were 759 
spun down, lysed and assayed for B-galactosidase activity. Data are the average of three separate experi-760 
ments (each experiment N=3). No expression was seen in a cidR mutant for any truncation (data not 761 
shown).     762 
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 764 
Figure 3.3: Mutation analysis of the cidABC and alsSD promoters. Mutations made in the cidABC 765 
(A) and alsSD (B) promoters and the effect on induction. Cultures were grown in flasks containing NZY + 766 
35 mM glucose at a 1:10 media to volume ratio. After six hours of growth samples of the cultures were 767 
spun down, lysed and assayed for B-galactosidase activity. Data are the average of three separate experi-768 
ments (each experiment N=3). No expression was seen in a cidR mutant for any truncation (data not 769 
shown).  770 
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CidR binds to the promoters of cidABC and alsSD  772 
Although the mutagenesis data demonstrated that the 5’-TAGTA-A/T-TACAAA-3’ 773 
sequence is important for glucose-inducible expression of the cidABC and alsSD operons, 774 
these results are not sufficient to demonstrate that these sequences are binding sites for 775 
CidR. To address this, we performed electrophoretic mobility-shift assays (EMSAs) us-776 
ing C-terminal His tag-labeled CidR protein and biotin-labeled DNA fragments from the 777 
cidABC and alsSD promoter regions. As shown in figure 3.4, incubation of purified CidR 778 
protein with either the cidABC (panel A) or alsSD (panel B) fragments resulted in a dose-779 
dependent shift in the migration of the target DNA. The addition of 200-fold excess unla-780 
beled specific competitor DNA effectively blocked the formation of higher order CidR-781 
DNA complexes, indicating that the binding of CidR to the target DNA was specific.  782 
To demonstrate that the sequence we uncovered was the CidR binding site we then 783 
tested regions upstream and downstream of the sequence from the cidABC promoter (Fig. 784 
3.5A). CidR binding was not observed in these regions of DNA, demonstrating the speci-785 
ficity of these protein-DNA interactions. Finally, we exploited the findings of our muta-786 
genesis experiments to test the sequences that altered cidABC expression in our EMSAs 787 
(3.5D). Complete replacement of the CidR binding site sequence with a random sequence 788 
in the competitor DNA eliminated competition, even at concentrations that were 200-fold 789 
excess of the labeled target DNA. This demonstrates the essentiality of the 5’-TAGTA-790 
A/T-TACAAA-3’ sequence is for CidR binding. Interestingly, we found that one of the 791 
mutations we made, 5’-AAAAAATACAAA-3’, eliminates induction (Fig. 3.3A) but 792 
does not block CidR binding (Fig. 3.5B).   793 
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 794 
 795 
Figure 3.4: CidR binds to the cidABC and alsSD promoters. A. cidABC and B. alsSD. Electropho-796 
retic Mobility-Shift Assays (EMSAs) were performed using increasing amounts of purified CidR protein 797 
and biotin-labeled cidABC promoter DNA as a target. Reaction mixtures were incubated for 30 minutes at 798 
room temperature and separated in a 6% TBE polyacrylamide gel. DNA was then transferred to a nylon 799 
membrane and developed as per the manufacturer’s instructions. Lanes 1 and 10 contain a no-protein con-800 
trol and 200-fold excess of unlabeled competitor DNA control, respectively.  801 
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 802 
 803 
Figure 3.5: Intact 12 bp element is required for CidR binding. A. Biotin-labeled primers were con-804 
structed for downstream (Lanes 1-3) and upstream (Lanes 4-6) of the putative CidR binding site. B. Com-805 
petitor DNA containing mutations was added in increasing amounts (range 0.2 to 200 fold excess) to 2000 806 
nM purified CidR incubated with biotin-labeled DNA. Mutations were made in the sequences shown.  807 
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These data demonstrate that the 5’-TAGTA-A/T-TACAAA-3’ element is a critical bind-808 
ing site for CidR-mediated control of cidABC and alsSD expression. 809 
 810 
CcpA directly regulates cidABC and alsSD induction  811 
In addition to the CidR binding site, we noticed the presence of a putative CcpA 812 
recognition site, so-called “CRE site”, directly upstream of the CidR-binding site in both 813 
the cidABC and alsSD promoter regions. It had previously been reported that disrupting 814 
CcpA altered biofilm formation and cidABC expression (122), though it wasn’t known if 815 
this effect was due to direct regulation by CcpA, nor if CcpA affected alsSD expression. 816 
We therefore assessed expression of both promoters in a ΔccpA mutant.  In agreement 817 
with the previous report (122), we found that both cidABC and alsSD expression was re-818 
duced in a ΔccpA mutant under inducing conditions (Fig. 3.6A). Quantitative RT-PCR 819 
confirmed that alteration of the expression of cidR was statistically insignificant in the 820 
ΔccpA mutant, thus ruling out that the reduced induction exhibited by cidABC and alsSD 821 
was due to altered CidR expression (Fig. 3.6B). To determine whether CcpA-mediated 822 
regulation of cidABC and alsSD was direct we performed EMSA experiments as de-823 
scribed above (Fig. 3.7). C-terminal His tag-labeled CcpA was affinity purified and incu-824 
bated with the same 60-bp biotin-labeled cidABC and alsSD promoter fragments that 825 
were used to assess CidR binding (Fig. 3.4). Analysis of the EMSA clearly showed that 826 
CcpA bound the target DNA in a dose-dependent manner for both promoters. Further-827 
more, the addition of 200-fold excess unlabeled specific competitor DNA effectively  828 
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 829 
Figure 3.6: Effect of disruption of ccpA on cidABC and alsSD induction. A. Induction of cidABC and  830 
alsSD in the wild-type and ΔccpA background. Cultures were grown in flasks containing NZY + 35 mM 831 
glucose at a 1:10 media to volume ratio. After six hours of growth samples of the cultures were spun down, 832 
lysed and assayed for B-galactosidase activity. Data are the average of three separate experiments (N=3). B. 833 
Transcription of cidR in the UAMS-1 and isogenic ccpA background. Cultures were grown for 3 hours in 834 
NZY + 35 mM glucose before mRNA isolation. Total RNA (500 ng) was converted to cDNA using the 835 
Quantitect Reverse Transcription Kit (Qiagen). The samples were then diluted 1:50, and the cDNA prod-836 
ucts were amplified using the LightCycler DNA Master SYBR green I kit (Roche Applied Science) follow-837 
ing the manufacturer’s protocol. The relative transcript levels were calculated using the comparative 838 
threshold cycle (CT) method (119) with normalization to the amount of sigA transcripts present in the RNA 839 
samples.  840 
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 841 
Figure 3.7: Binding of CcpA to the cidABC and alsSD promoters. Purified CcpA was added in increas-842 
ing concentrations (range 100 to 7000 nM) to biotin labeled target DNA for the cidABC (A) and alsSD (B). 843 
Reaction mixtures were incubated for 30 minutes at room temperature and separated on a 6% TBE poly-844 
acrylamide gel. DNA was then transferred to a nylon membrane and developed as per the manufacturer’s 845 
instructions. Lanes 1 and 9 contain a no-protein control and 200-fold excess of unlabeled competitor DNA 846 
control, respectively.  847 
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 849 
Figure 3.8: Nucleotide sequences of the cid and als promoters. A. cidABC and B. alsSD promoters. 850 
Truncations created are denoted by numbers indicating bp before the transcription start site. The CidR and 851 
CcpA binding sites are underlined and labeled. First methionine of CidA and AlsS are colored green.  852 
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CGCCATAAAACGACAATTTCAAACCGTCATTGACTAAAGACCTCATTCTCAAAT
ATGCTAACAATCCTCCACACCAATCAATCCAACATCCCTTATAATCACTCCCTT
CAAAATCTACTCATGCATTTTTGGAATACTTAGTATTACAAATAACGATTTTTA
TTCATCTTACAAAGGATATATAATGTACTGAAGGCAATTTTTATGTATCACAAA
TCTAATTGTATATGTAAAGTTTTGATAAATATCATTAATTTTACATAACTATCA
TTAGATTACAAATCACAATGTAATTACATGTAATACACATCTACACATCACATT
TGAAGGGAAATGAATATAAATG
-35
*-10
A.
B.
CidR
CidR
CRE
CRE
CRE
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blocked the formation of higher order CcpA-DNA complexes, indicating that the binding 853 
of CcpA to the target DNA was specific. These data demonstrate that CcpA directly regu-854 
lates cidABC and alsSD. The sequence of the cidABC and alsSD promoters, with the 855 
CidR and CRE sites marked can be seen in figure 3.8. 856 
 857 
CidR and carbon catabolite repression are necessary for the induction of cidABC and 858 
alsSD  859 
Because ccpA is the primary regulator of CCR in Gram positives (74), we tested what 860 
effect other carbon sources would have on the induction of cidABC and alsSD. Our hy-861 
pothesis was that a carbon source whose catabolism did not result in the formation of 862 
glucose 6-phosphate and fructose 1,6 bis-phosphate would not result in induction of 863 
cidABC. We grew wild-type cultures in media containing either glucose (35 mM), fruc-864 
tose (42 mM) or glycerol (70 mM) as a carbon source. Like glucose, fructose was found 865 
to cause induction of both cidABC and alsSD (Fig. 3.9). The addition of glycerol did not 866 
promote induction from either promoter. The possibility that S. aureus was not consum-867 
ing glycerol as a carbon source was discounted by measuring the pH. By six hours 868 
growth all cultures grown with an extra carbon source had a decrease in pH below 5.5 869 
(data not shown), suggesting that acetate was being produced. Utilization of glycerol will 870 
not lead to the formation of glucose 6-phosphate and fructose 1,6 bis-phosphate, and thus 871 
will not promote CCR. These experiments demonstrate that CCR is a necessity for 872 
cidABC and alsSD induction.  873 
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We also confirmed this by performing a second experiment to observe the effect of 874 
disrupting ccpA in an ackA mutant background. Our lab has shown that an ackA mutant 875 
has increased induction of cidABC (72). Importantly, this occurs without the addition of 876 
35 mM of glucose or the acidification of the media, thus giving another means of deter-877 
mining the contribution of CcpA-mediated CCR to cidABC induction. As can be seen in 878 
figure 3.10, the disruption of ccpA in the ackA background eliminates induction to the 879 
same extent as disrupting cidR in the ackA background. This demonstrates the need for 880 
CcpA even when CCR is not active.  881 
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 882 
Figure 3.9: Effect of alternative carbon sources on cidABC and alsSD induction. Cultures containing 883 
the A. cidABC reporter or B. the alsSD reporter were grown in flasks at a 1:10 media to volume ratio. Me-884 
dia was NZY with no additives, + 35 mM glucose, + 42 mM fructose or + 70 mM glycerol. After six hours 885 
of growth samples of the cultures were spun down, lysed and assayed for B-galactosidase activity. Data are 886 
the average of two separate experiments.  887 
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 888 
Figure 3.10: CidR and CcpA are required for full induction of cidABC. Transcription of cidA in the 889 
wild-type, ΔcidR, ΔackA ΔcidR, ΔackA, ΔccpA, and ΔackA ΔccpA backgrounds. Cultures were grown for 3 890 
hours in TSB + 35 mM glucose before mRNA isolation. Total RNA (500 ng) was converted to cDNA using 891 
the Quantitect Reverse Transcription Kit (Qiagen). The samples were then diluted 1:50, and the cDNA 892 
products were amplified using the LightCycler DNA Master SYBR green I kit (Roche Applied Science) 893 
following the manufacturer’s protocol. The relative transcript levels were calculated using the comparative 894 
threshold cycle (CT) method (119) with normalization to the amount of sigA transcripts present in the RNA 895 
samples. (*P<0.001. **p<0.05) 896 
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Identification of other potential effectors of cidABC expression  897 
Having established the roles of CidR and CcpA in the regulation of cidABC and 898 
alsSD expression, along with the findings that the SrrAB two-component system plays an 899 
important role in the regulation of cidABC expression, we next sought to identify meta-900 
bolic effectors that influence the expression of this operon. To accomplish this, we de-901 
signed an unbiased, transposon mutagenesis approach to identify additional fac-902 
tors/metabolic pathways that influence cidABC expression. We first generated a reporter 903 
strain derivative of S. aureus JE2 (102)  that contained a chromosomally encoded 904 
PcidABC::lacZ fusion construct that was inserted in the geh gene (strain KB6001). As 905 
above, we demonstrated that expression of lacZ was inducible by growth under glucose-906 
excess conditions in a cidR-dependent fashion (data not shown), thus, giving confidence 907 
that this reporter construct reflected the normal control of the cidABC promoter. We then 908 
performed transposon mutagenesis as has been described previously (102) on KB6001 909 
and screened for colonies that displayed altered cidABC expression. In one screen, we 910 
surveyed for mutants that caused an increase in cidABC expression (increased blue color) 911 
under non-inducing conditions. In another we surveyed for mutants that caused a de-912 
crease in cidABC expression (decreased blue color) under inducing conditions. The re-913 
sults of the plate screen are displayed in Table 4. Using this method we found two poten-914 
tial effectors of positive cidABC induction; acetate kinase (ackA) and 915 
phosphoglucosemutase/phosphomannomutase (pgcA). Our lab has reported previously 916 
that disrupting ackA increases cidABC induction (72), indicating that the screen was 917 
working as predicted. 918 
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We then took those mutants recovered on TSA plates and confirmed altered cidABC 919 
induction by quantitative beta-galactosidase assays to verify positive hits. Figure 3.11 920 
displays the remaining potential mutants. Of particular interest to us from this screen 921 
were the ptsH and ptsI mutants; phosphocarrier protein HPr and phosphoenolpyruvate-922 
protein phosphotransferase, respectively. As these genes are part of the PTS system and 923 
CCR, they influence CcpA binding, further demonstrating that the screen could identify 924 
effectors of cidABC transcription.   925 
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Table 4. Results of transposon mutagenesis screen 926 
Locus Description Gene Name 
Increase   
SAUSA300_1657 acetate kinase  ackA  
SAUSA300_2433 phosphoglucomutase/phosphomannomutase 
family protein 
pgcA  
Decrease   
   
SAUSA300_1327 cell surface protein ebh  
SAUSA300_0659 sugar efflux protein, MFS family, sugar:cation symporter  
SAUSA300_0352 ABC transporter, ATP-binding protein  
SAUSA300_2645 glucose-inhibited division protein A gidA  
SAUSA300_0983 phosphocarrier protein HPr  Hpr  
SAUSA300_0984 phosphoenolpyruvate-protein 
phosphotransferase  
ptsI  
SAUSA300_0388 inosine-5'-monophosphate dehydrogenase  guaB  
SAUSA300_0984 phosphoenolpyruvate-protein 
phosphotransferase 
ptsI  
SAUSA300_0388 inosine-5'-monophosphate dehydrogenase guaB  
SAUSA300_1507 glucokinase glk  
SAUSA300_2059 ATP synthase F1, gamma subunit atpG  
SAUSA300_0495 hypothetical protein  
SAUSA300_1902 Conserved hypothetical protein, Lactonase  
SAUSA300_0552 Conserved hypothetical protein, LmbE family 
protein 
 
SAUSA300_2059 ATP synthase F1, gamma subunit atpG  
SAUSA300_1624 upstream of MutT/nudix family protein  
SAUSA300_0192 Conserved hypothetical protein murQ? 
Intergenic  metallopeptidase  
SAUSA300_2588 preprotein translocase  SecY 
Intergenic  upstream of rrsC, 16s ribosomal RNA  
SAUSA300_1393 phiSLT ORF2067-like protein, phage tail tape  measure protein 
SAUSA300_1015 cytochrome oxidase assembly protein ctaA  
SAUSA300_0764 ribonuclease R rnr  
SAUSA300_1259 ImpB/MucB/SamB family protein; DNA dam-
age repair 
 
SAUSA300_0123 siderophore biosynthesis protein, IucC family  
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 927 
SAUSA300_1286 aspartate kinase  
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 928 
Figure 3.11: cidABC induction in isolated transposon mutants.  Transposon mutants listed in Table 4 929 
were tested for cidABC induction in planktonic culture. Cultures were grown in flasks containing NZY + 35 930 
mM glucose at a 1:10 media to volume ratio. After six hours of growth samples of the cultures were spun 931 
down, lysed and assayed for β-galactosidase activity. Data are the average of at least two separate experi-932 
ments. Mutants shown are remaining mutants after eliminating false positives.933 
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Discussion 934 
In this study we sought to better understand the regulation of the cidABC and alsSD 935 
operons. Our lab has demonstrated the necessity of CidR for their induction (64, 65). 936 
However, it was unknown what DNA sequence to which CidR binds, and thus whether or 937 
not CidR-mediated regulation of cidABC and alsSD was direct or through an intermediate 938 
transcriptional regulator. CidR is a member of the LTTR family of proteins (65), which 939 
have a characteristic binding sequence termed the T-N11-A motif (87). However, the 940 
promoters of cidABC and alsSD are AT-rich and contain an abundance of potential T-941 
N11-A motifs (Fig. 3.8), so a homologous sequence with a T-N11-A motif between the 942 
promoters of cidABC and alsSD that could be the CidR-binding site was not readily ap-943 
parent. As it has previously been shown that disrupting out cidR eliminates cidABC and 944 
alsSD induction (64, 65) we created a series of nested truncations that removed all or part 945 
of the CidR binding site. Examination of expression from the truncations revealed a re-946 
gion of the DNA that was essential for induction in both promoters (Fig. 3.2). Upon ex-947 
amination of the DNA sequence, a conserved element was noted, 5’-TAGTA-A/T-948 
TACAAA-3’. Mutations made in this sequence eliminated induction in both the cidABC 949 
and alsSD promoters (Fig. 3.3), further demonstrating the importance of this element. 950 
EMSAs performed (Fig. 3.4 and 3.5) confirmed that CidR directly binds to this element.  951 
CidR has been demonstrated to regulate only the cidABC and alsSD operons (64), de-952 
spite the fact that LTTRs are usually thought of as global transcriptional regulators (87). 953 
Using the newly discovered CidR binding sequence we performed a search for other po-954 
tential CidR-binding sites in the UAMS-1 genome. The 5’-TAGTA-A/T-TACAAA-3’ 955 
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motif occurs in only 4 other locations in hypothetical genes, and is not found in the pro-956 
moters of genes or operons other than cidABC and alsSD (data not shown). This makes us 957 
confident that the 5’-TAGTA-A/T-TACAAA-3’element is the target of CidR binding.  958 
Interestingly, we found that one of the mutations we made, 5’-AAAAAATACAAA-959 
3’, eliminates induction (Fig. 3.3) but does not block CidR binding (Fig. 3.5B). The ca-960 
nonical LTTR binding region contains two separate binding sites separated by a few bp, 961 
termed the Recognition Binding Site (RBS) and the Activation Binding Site (ABS). The 962 
LTTR binds each site as a dimer, the dimers interact to form a tetramer, and the tetramer 963 
acts to bend the DNA (87). It is thought that the high angle of the bent DNA impedes 964 
formation of the RNA transcription bubble. In the presence of a signal the LTTR under-965 
goes a conformational change, causing the tetramer to shift on the DNA and relax the an-966 
gle. The new angle then allows for the formation of an RNA transcription bubble, and 967 
facilitates transcription. This model of LTTR regulation has been termed the ‘sliding di-968 
mer’ model (97). By replacing four bp of the 5’ half site with adenines, it would appear 969 
that we have made it so that CidR can still bind the DNA but cannot bend the DNA into a 970 
conformation that would lead to induction of cidABC transcript.  971 
Our lab had also proven previously that SrrAB acts as a direct regulator of cidABC 972 
expression (104), so we were curious what other transcriptional regulators besides CidR 973 
and SrrAB would play a direct role in the regulation of cidABC and alsSD. While produc-974 
ing truncations we noticed the presence of putative CRE sites directly upstream of the 975 
CidR-binding site in both the cidABC and alsSD promoter regions. We therefore assessed 976 
expression of both promoters in a ΔccpA mutant.  We found that both cidABC and alsSD 977 
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expression was reduced in a ΔccpA mutant under inducing conditions (Fig. 3.6A), and 978 
that this regulation was direct (Fig. 3.7). While it had previously been reported that dis-979 
rupting CcpA altered biofilm formation and cidABC expression (122), these results con-980 
firm that this is due to direct regulation by CcpA. This is also the first report of CcpA-981 
mediated regulation of alsSD expression in S. aureus.  982 
Our transposon mutagenesis screen suggested that CCR could play a role beyond me-983 
tabolism, so we investigated the transcriptional regulator CcpA, as it has been suggested 984 
before that CcpA plays a role in cidABC induction (122). Here we show that CcpA is re-985 
quired for the induction of cidABC and also alsSD (Fig. 4A). Importantly, CcpA binds 986 
both promoters (Fig. 4B-C), demonstrating for the first time that CcpA-mediated regula-987 
tion of cidABC and alsSD is direct.   988 
In conclusion, our work here demonstrates two novel findings concerning cid-989 
mediated cell death in Staphylococcus aureus. We used genetic techniques to create trun-990 
cations and mutations in the cidABC and alsSD promoters to ultimately define the se-991 
quence of the CidR binding site, 5’-TAGTA-A/T-TACAAA-3’. We have also found that 992 
cid-mediated cell death is directly linked to the phosphotransferase system and central 993 
metabolism through CcpA-mediated transcription. Our transposon mutagenesis screen 994 
revealed other potential modulators for further study.  Our work here expands our under-995 
standing of cell death in bacteria.  996 
997 
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Chapter IV. SrrAB modulates Staphylococcus aureus cell death through regula-998 
tion of cidABC transcription 999 
Introduction 1000 
A fundamental aspect of bacterial biofilms is the synthesis of self-produced extracel-1001 
lular matrix molecules that are critical for intercellular adherence and binding to surfaces 1002 
(34). These molecules are diverse in nature and include specific carbohydrates, proteins, 1003 
and extracellular DNA (eDNA). In Staphylococcus aureus, it has been demonstrated that 1004 
eDNA is released as a consequence of the death and lysis of a subpopulation of cells in 1005 
the biofilm via a process termed bacterial programmed cell death (PCD) (32, 41, 121). 1006 
The surviving cells derive benefit from the death of the subpopulation by using the eDNA 1007 
as part of the scaffolding of the matrix. Although the mechanism(s) controlling cell death 1008 
remain to be elucidated, this process is known to involve the products of the cidABC and 1009 
lrgAB operons, which share many features in common with the regulatory components 1010 
known to regulate PCD in more complex eukaryotic organisms (41, 56, 123). 1011 
The current model for the role of the cidABC and lrgAB operons in cell death is based 1012 
on the functions of holins and antiholins in the control of cell death and lysis during the 1013 
lytic cycle of a bacteriophage infection (50). Similar to holins, CidA is thought to have 1014 
the capacity to form pores in the cytoplasmic membrane by oligomerization, leading to 1015 
depolarization of the membrane and cell death, followed by the activation of murein hy-1016 
drolase activity and cell lysis (56). LrgA, as an anti-holin (52), is envisioned to oppose 1017 
the activity of CidA, interfering with its ability to depolarize the membrane and cause 1018 
subsequent death and lysis (50). Thus, the balance between CidA and LrgA is thought to 1019 
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determine whether a cell will live or die. Indeed, both CidA and LrgA have been shown 1020 
to associate with the cytoplasmic membrane and oligomerize into high molecular weight 1021 
complexes (53). More recently, cidC-encoded pyruvate oxidase (60) was shown to pro-1022 
mote cell death during stationary phase and biofilm development by producing acetate 1023 
and promoting the acidification of the growth media (61). Thus, we hypothesize that the 1024 
cid operon influences cell death both by affecting murein hydrolase activity and by acidi-1025 
fying the local environment.  1026 
The regulation of cidABC expression is known to be mediated by CidR, which is re-1027 
quired for the induction of expression during growth in excess glucose (50) or low oxy-1028 
gen (31). Recent studies have also demonstrated that cidABC expression is influenced by 1029 
the SrrAB two-component system, known to be important for anaerobic growth and sur-1030 
vival (81). Disruption of srrAB resulted in enhanced cell death and decreased biofilm 1031 
thickness (83, 84), likely as a result of the role this regulatory system has in adaptation to 1032 
an anaerobic environment. In the current study we demonstrate that the increased death 1033 
exhibited by the srrAB mutant is a function of increased cidABC expression caused by the 1034 
srrAB mutation. However, in contrast to our expectations, the increased death observed 1035 
was not a function of increased acetate accumulation. Rather, death was associated with 1036 
cidB-dependent increased reactive oxygen species (ROS) accumulation. Thus, these re-1037 
sults are the first to demonstrate a positive role for CidB in cell death.  1038 
 1039 
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Results 1040 
Disruption of srrAB enhances weak acid-dependent death  1041 
Previous studies have demonstrated a pronounced cell death phenotype associated 1042 
with the ΔsrrAB mutation (83, 84). Given that transcription profiling experiments sug-1043 
gested that the SrrAB regulatory system has a negative effect on cidABC transcription 1044 
(83), and that media acidification due to the accumulation of acidic fermentative metabo-1045 
lites can influence cell fate (61), we initially tested the hypothesis that increased cidC-1046 
dependent acetate production was responsible for the decreased survival of a S. aureus 1047 
ΔsrrAB mutant relative to the wild-type strain. Thus, we monitored the survival of the 1048 
wild-type strain and the ΔsrrAB mutant in stationary phase following growth in tryptic 1049 
soy broth (TSB) supplemented with excess glucose (35 mM) as previously described (61). 1050 
Indeed, the ΔsrrAB mutant exhibited an increased rate of cell death in the presence of 35 1051 
mM glucose compared to the wild-type strain, but demonstrated similar survival in sta-1052 
tionary phase when grown in the presence of 14 mM glucose (Fig. 4.1A) indicating that 1053 
acidification is necessary for cell death to occur. Additionally, consistent with a role for 1054 
acetate in modulating the rate of cell death associated the ΔsrrAB mutant during station-1055 
ary phase, cell viability of both the wild-type and mutant strains was dramatically in-1056 
creased when grown in media (TSB supplemented with 35 mM glucose) buffered to a pH 1057 
of 7.4 with 50 mM MOPS (Fig. 4.5A), most likely due to the inability of acetate (pKa = 1058 
4.8) to permeate cells and acidify the cytoplasm under relatively neutral conditions (61). 1059 
Much to our surprise, however, measurements of acetate production and culture pH re-1060 
vealed that the srrAB mutant produced nearly identical amounts of acetate compared to  1061 
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 1062 
Figure 4.1. Acidic conditions adversely affect survival of the ΔsrrAB mutant in stationary phase. A. S. 1063 
aureus UAMS-1 (WT) and the isogenic ΔsrrAB mutant cell viabilities (cfu/ml, mean ± SEM) were moni-1064 
tored every 24 h over a period of five days in TSB + 14 mM glucose or TSB + 35 mM glucose. Cultures 1065 
were grown at 37°C under aerobic conditions. B. Acetate levels accumulated in S. aureus UAMS-1 (WT) 1066 
and the isogenic ΔsrrAB mutant culture supernatants were measured after 24 h of growth in TSB + 35 mM 1067 
glucose using a commercially available kit (R-biopharm). C. The corresponding pH values of the culture 1068 
supernatants from panel B.  1069 
 1070 
 1071 
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the wild-type strain (Fig. 4.1B) and exhibited similar culture pH values (Fig. 4.1C) when 1072 
grown in the presence of 35 mM glucose. Thus, in contrast to our hypothesis, these data 1073 
indicate that the decreased viability of the ΔsrrAB mutant during stationary phase is not 1074 
due to the increased production and release of acetate. 1075 
 1076 
Decreased srrAB mutant viability is dependent on enhanced cidABC transcription  1077 
Although the increased death of the ΔsrrAB mutant in stationary phase did not corre-1078 
late with acetate excretion, cidABC expression was still involved in this process. As 1079 
shown in Figure 4.2A, survival of the srrAB mutant during stationary phase was dramati-1080 
cally improved by disruption of the cidABC operon, to levels similar to that associated 1081 
with cells containing the cidABC mutation alone, as well as to those observed previously 1082 
for an S. aureus strain containing the cidC deletion alone (61). To confirm that disruption 1083 
of srrAB results in increased cidABC transcription, we engineered a reporter construct, 1084 
pIHW10lac, that contained the cidABC promoter fused to a lacZ reporter. Both the wild-1085 
type and the ΔsrrAB mutant strains containing the reporter plasmid were grown in media 1086 
containing 35 mM glucose and assayed for β-galactosidase activity. As shown in Figure 1087 
4.2B, srrAB disruption resulted in an approximately 4-fold increase in cidABC expression 1088 
compared to the wild-type strain, consistent with previously published results (83). Com-1089 
plementation of srrAB in trans under the control of its native promoter restored cidABC 1090 
promoter activity to wild-type levels (Fig. 4.2B). To determine whether SrrA directly 1091 
binds the cidABC promoter region, we performed electrophoretic mobility shift assays 1092 
(EMSA) (Fig. 4.2C). C-terminal His tag-labeled SrrA was affinity purified and incubated  1093 
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 1094 
Figure 4.2. The ΔsrrAB phenotype requires srrAB-dependent cidABC expression. A. S. aureus UAMS-1095 
1 (WT) and the isogenic ΔsrrAB, ΔcidABC, and ΔsrrABΔcidABC mutant cell viabilities (cfu/ml, mean ± 1096 
SEM) were monitored every 24 h over a period of five days in TSB + 35 mM glucose. Cultures were grown 1097 
at 37°C under aerobic conditions. B. S. aureus cells containing a cidABC promoter fused to lacZ were 1098 
grown to post-exponential phase and assayed for β-galactosidase activity. C. Electrophoretic Mobility-Shift 1099 
Assays (EMSAs) were performed using increasing amounts of purified SrrA protein and biotin-labeled 1100 
cidABC promoter DNA as a target. Reaction mixtures were incubated for 30 minutes at room temperature 1101 
and separated in a 6% TBE polyacrylamide gel.  1102 
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with 60-bp biotin-labeled DNA fragments of the cidABC promoter region including the 1103 
putative SrrA binding site (Fig. 4.5B). Analysis of the EMSA clearly showed that SrrA 1104 
bound the target DNA in a dose-dependent manner. Furthermore, the addition of 200-fold 1105 
excess unlabeled specific competitor DNA effectively blocked the formation of higher 1106 
order SrrA-DNA complexes, indicating that the binding of SrrA to the target DNA was 1107 
specific.  Taken together, these data demonstrate that SrrA acts as a direct repressor of 1108 
cidABC transcription, and that the decreased viability of the srrAB mutant in stationary 1109 
phase is a function of enhanced cidABC expression, but not a result of increased produc-1110 
tion of CidC-mediated acetate excretion into the culture medium.  1111 
 1112 
The ΔsrrAB mutant generates increased levels of reactive oxygen species  1113 
Given that death induced by weak acids is associated with the inhibition of respiration 1114 
and the production of reactive oxygen species (ROS) in S. aureus (61), we also tested the 1115 
hypothesis that the decreased survival of the srrAB mutant in stationary phase was due to 1116 
increased sensitivity to ROS. Both the wild-type strain and ΔsrrAB mutant were grown in 1117 
TSB supplemented with 35 mM glucose and co-stained with cyano-2, 3-ditolyl 1118 
tetrazolium chloride (CTC) and 3’-(p-hydroxyphenyl) fluoroscein (HPF) at 24 h and 72 h, 1119 
which have previously been used to distinguish between respiring bacterial populations 1120 
and those generating deleterious hydroxyl radicals (124, 125). As expected under these 1121 
conditions, both the wild-type strain and ΔsrrAB mutant exhibited respiring populations 1122 
at 24 h (Fig. 4.3A). However, these populations declined by 72 h and were replaced by a 1123 
ROS-generating population (HPF positive) (Fig. 4.3A).  Interestingly, the mutant  1124 
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 1125 
Figure 4.3. Effect of the ΔsrrAB mutation on ROS production and survival. A. S. aureus UAMS-1 1126 
(WT) and isogenic ΔsrrAB mutant cells were collected at one and three days of growth in TSB + 35 mM 1127 
glucose at 37°C under aerobic conditions, stained with CTC and HPF, and then analyzed by flow cytometry. 1128 
B. Aerobically grown cells of UAMS-1 and ΔsrrAB mutant (TSB-35 mM glucose) were shifted to an an-1129 
aerobic chamber after 24 hours of growth and monitored for cell viability every 24 h over a period of five 1130 
days in TSB + 35 mM glucose. C. Growth of S. aureus UAMS-1 (WT) and ΔsrrAB mutant cultures con-1131 
taining 5 mM H2O2 were monitored for 24 h at 37°C in a Tecan infinite 200 spectrophotometer under max-1132 
imum aeration. 1133 
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produced 15% more HPF-positive cells at 72 h of growth compared to the wild-type 1134 
strain (Fig. 4.3A). These observations suggest that increased cell death observed in the 1135 
ΔsrrAB mutant may be a consequence of ROS accumulation. Evidence supporting this 1136 
hypothesis was obtained by shifting the ΔsrrAB mutant to anaerobic conditions following 1137 
24 h of aerobic growth in TSB supplemented with 35 mM glucose (Fig. 4.3B).  This 1138 
strategy allowed the cells to remain under weak acid stress, but devoid of the ROS ob-1139 
served at 72 h of growth due to the anoxic growth conditions. Consistent with a signifi-1140 
cant role for ROS in catalyzing cell death of the ΔsrrAB mutant, we observed that a shift 1141 
to anaerobiosis improved the survival of the ΔsrrAB mutant, even beyond that observed 1142 
for the wild-type strain. Finally, to test the relative sensitivity of the ΔsrrAB mutant to 1143 
oxidative stress, we performed growth experiments in the presence and absence of hy-1144 
drogen peroxide. As shown in Figure 4.3C, analysis of cell growth (OD600) revealed that 1145 
the ΔsrrAB mutant was more sensitive to hydrogen peroxide challenge (5 mM) than the 1146 
wild-type strain. Together, these data suggest a role for SrrAB in negatively regulating 1147 
cell death under acidic conditions by decreasing the generation of ROS while at the same 1148 
time increasing resistance to these toxic molecules, possibly by modulating antioxidant 1149 
activities. 1150 
 1151 
Inactivation of cidB rescues the ∆srrAB mutant from stationary phase cell death  1152 
Although a role for the SrrAB regulon in an adaptive response to anaerobiosis has 1153 
been demonstrated, its ability to modulate ROS sensitivity has not been reported. Since 1154 
disruption of cidABC increased stationary phase survival (Fig. 4.2A), and since CidA is a 1155 
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integral membrane protein that has holin-like properties proposed to be involved in the 1156 
control of cell death, we reasoned that its expression in the context of the srrAB mutant 1157 
background may affect stationary phase survival. To test this hypothesis, in-frame and 1158 
isogenic deletion mutants (ΔsrrABΔcidA, ΔsrrABΔcidB and ΔsrrABΔcidC) were generat-1159 
ed and monitored for their survival relative to the ΔsrrAB mutant. Consistent with our 1160 
previous studies of a ΔcidC mutant, a triple mutant in which both srrAB and cidC were 1161 
disrupted (ΔsrrABΔcidC) exhibited a decrease in ROS generation and increased popula-1162 
tion of respiring cells at day 3 (Fig. 4.4A), resulting in increased stationary phase survival 1163 
(Fig. 4B). This was due to reduced acetate excretion (Fig. 4.4C). Interestingly, despite 1164 
generating higher acetate levels than the ΔsrrABΔcidC mutant (Fig. 4.4C), as well as a 1165 
lower pH (Fig. 4.4D), the ΔsrrABΔcidB mutant phenocopied the ΔsrrABΔcidC mutant in 1166 
terms of survival (Fig. 4.4B) and the presence of a healthy respiring population and re-1167 
duced generation of ROS relative to the wild-type strain (Fig. 4.4A). A polar effect of 1168 
cidB mutation on the cidC allele was ruled out as trans-complementation of cidB in the 1169 
ΔsrrABΔcidB mutant restored the rates of cell death (Fig 4.5C) to levels observed in the 1170 
ΔsrrAB mutant. Consistent with its decreased ROS production and similar to the 1171 
ΔsrrABΔcidC mutant, the ΔsrrABΔcidB mutant was more resistant to oxidative stress 1172 
upon hydrogen peroxide challenge (Fig. 4.4E), a phenotype that could also be comple-1173 
mented in the latter strain by expressing cidB in trans (Fig 4.5D). Taken together, these 1174 
data suggest that over-expression of CidB in the ΔsrrAB mutant induces cell death by en-1175 
hancing ROS production and increasing sensitivity to oxidative stress. In contrast, alt-1176 
hough the cidA gene is co-expressed with cidB and cidC, the ΔsrrABΔcidA mutant exhib-1177 
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ited phenotypes similar to that of the ΔsrrAB mutant with respect to ROS production, 1178 
acetate generation and survival in stationary phase (Fig. 4.4A-D). 1179 
 1180 
Role of superoxide dismutase and catalase in the increase sensitivity of srrAB to ROS  1181 
When srrAB is transferred to anaerobic conditions after 24 hours aerobic growth it 1182 
demonstrates improved survival compared to the wild-type, demonstrating that the srrAB 1183 
mutant has increase sensitivity to ROS (Fig. 4.3B). Since cidB would appear to reduce 1184 
the production of reactive oxygen species (Fig. 4.4A) we reasoned that the ΔcidB muta-1185 
tion would not rescue the ΔsrrAB mutant under anaerobic conditions. To test this hypoth-1186 
esis we grew our mutants (ΔsrrAB ΔcidA, ΔsrrAB ΔcidB and ΔsrrAB ΔcidC) for 24 hours 1187 
aerobically before transferring the cultures to an anaerobic chamber, and monitored their 1188 
survival relative to the ΔsrrAB mutant via cfu count (Fig. 4.6A). The srrAB cidC mutant 1189 
displays improved survival compared to the srrAB mutant, consistent with decreased 1190 
acidic stress due to lower concentrations of acetate within the first 24 hours. The srrAB 1191 
cidA mutant demonstrates decreased survival compared to the srrAB mutant, a result con-1192 
sistent with the increased acetate concentration that results with the disruption of cidA. In 1193 
keeping with our hypothesis, disrupting cidB does not rescue srrAB to the extent that as 1194 
disruption of cidC under anaerobic conditions, confirming that CidB plays a role in ROS 1195 
sensitivity. Interestingly, ΔsrrAB ΔcidB demonstrated an intermediate phenotype between 1196 
ΔsrrAB ΔcidC and ΔsrrAB for the first 3 days, before experiencing massive die off on the 1197 
4
th
 day, ending the experiment with a population comparable to that ΔsrrAB ΔcidA. This  1198 
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 1199 
Figure 4.4. Role of the cidABC genes on ROS production and survival. A. S. aureus ΔsrrAB, 1200 
ΔsrrABΔcidA, ΔsrrABΔcidB, and ΔsrrABΔcidC mutants were collected at one and three days of growth in 1201 
TSB + 35 mM glucose at 37°C under aerobic conditions, stained with CTC and HPF, and then analyzed by 1202 
flow cytometry. B. Cell viabilities (cfu/ml, mean ± SEM) were monitored every 24 h over a period of five 1203 
days in TSB + 35 mM glucose. C. Acetate concentrations in culture supernatants were measured every 24 h 1204 
over a period of five days using a commercially available kit (R-biopharm). D. The pH of the culture su-1205 
pernatants. E. Overnight cultures were resuspended to an OD600 of 0.06 in TSB. Growth of the S. aureus 1206 
mutants in the presence of 5 mM H2O2 were monitored for 24 h at 37°C in a Tecan infinite 200 spectropho-1207 
tometer under maximum aeration.   1208 
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would suggest that CidB plays not only a role in sensitivity to ROS, but also a role in acid 1209 
resistance.  1210 
Given that the srrAB mutant displayed increased sensitivity to ROS (Fig. 4.3B) it 1211 
seemed likely that disrupting srrAB had altered transcription of superoxide dismutase or 1212 
catalase. When the transcription of these genes was investigated, however, there was no 1213 
significant alteration in the expression of the genes encoding these enzymes in the 1214 
ΔsrrAB mutant (Fig. 4.6B). Thus, the sensitivity to ROS demonstrated by the ΔsrrAB 1215 
mutant is the result of something other than an inability to detoxify increased ROS.  1216 
 1217 
SrrAB-mediated repression of the alsSD promoter  1218 
We reasoned that because the synthesis of 2,3-butanediol from acetoin consumes 1219 
NADH + H
+
, which could potentially be used for redox balance and cytoplasmic pH ho-1220 
meostasis SrrAB would not repress alsSD.  This hypothesis is supported by the lack of a 1221 
change in alsSD induction in a srrAB mutant under aerobic conditions with excess glu-1222 
cose (Fig. 4.7A). Interestingly, when the concentration of acetoin in the supernatant was 1223 
measured during stationary phase survival, the srrAB mutant demonstrated a statistically 1224 
significant increase in acetoin concentration compared to wild-type (Fig. 4.7B). Given 1225 
our other data it would seem most likely that disrupting srrAB had altered metabolism to 1226 
redirect carbon into acetoin rather than affecting transcription of alsSD directly. However, 1227 
for our assays we measured induction of alsSD at 6 hours growth with excess glucose, 1228 
and could not discount the possibility that alsSD induction was altered at later time points. 1229 
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To determine if alsSD was under SrrAB-mediated regulation we decided to perform 1230 
EMSAs with our purified SrrA protein.  1231 
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 1232 
Figure 4.5.  Complementation of CidB phenotypes. A. Stationary phase viabilities were monitored for 1233 
cultures following growth in TSB-35 mM glucose over a period of 5 days. B. Sequence of the cidABC 1234 
promoter. -35 and -10 are underlined. Transcription and translation start sites are denoted by an arrow and 1235 
asterisk, respectively. The putative SrrA binding site is underlined and in bold C. Stationary phase viabili-1236 
ties were monitored for cultures following growth in TSB-35 mM glucose over a period of 5 days. D. 1237 
Overnight cultures were resuspended to an OD600 of 0.06 in TSB. Cultures were challenged with 5 mM 1238 
H2O2 and growth was monitored for 24 hours at 37°C in a Tecan infinite 200 spectrophotometer under 1239 
maximum aeration.  1240 
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 1241 
Figure 4.6. Effect of anaerobic conditions on stationary phase survival of individual cidABC muta-1242 
tions in the ΔsrrAB mutant background. A.  Aerobically grown cells of ΔsrrAB, ΔsrrABΔcidA, 1243 
ΔsrrABΔcidB and ΔsrrABΔcidC (TSB-35 mM glucose) were shifted to an anaerobic chamber after 24 1244 
hours of growth and monitored for cell viability every 24 h over a period of five days in TSB + 35 mM 1245 
glucose. B. Transcription of superoxide dismutase (sodA) and catalase (kat) in the ΔsrrAB mutant. Cultures 1246 
were grown to an OD600 of 0.4 in a 3 to 5 media to flask ratio to imitate microaerobic conditions. The cul-1247 
tures were then exposed to 10 mM hydrogen peroxide for 10 minutes and then isolated for mRNA for RT-1248 
PCR. Data are the average of two separate experiments. 1249 
srrAB
F
o
ld
 i
n
d
u
c
ti
o
n
 r
e
la
ti
v
e
 t
o
 W
T
so
dA ka
t
0
1
2
3
4
A.
B.
86 
 
 1250 
Figure 4.7. Effect of disruption of srrAB on alsSD transcription.  A. S. aureus cells containing an alsSD 1251 
promoter fused to lacZ were grown to post-exponential phase and assayed for β-galactosidase activity. B. 1252 
Acetoin concentrations in culture supernatants were measured every 24 h over a period of five days. 200 1253 
µL of supernatant was mixed with 140 µL 0.5% creatine, 200 µL 5% α-napthol, and 200 µL 40% KOH. 1254 
The sample was incubated for 15 to 30 minutes. The OD560 was measured and used to determine the con-1255 
centration of acetoin. 1256 
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 1259 
 1260 
Figure 4.8. SrrA binds to the promoter of alsSD. A. Electrophoretic Mobility-Shift Assays (EMSAs) 1261 
were performed using increasing amounts of purified SrrA protein and biotin-labeled alsSD promoter DNA 1262 
as a target. Reaction mixtures were incubated for 30 minutes at room temperature and separated in a 6% 1263 
TBE polyacrylamide gel. B. Nucleotide sequence of the alsSD promoter displaying putative SrrA binding 1264 
sites.  1265 
alsSD promoter
CAAAATCTACTCATGCATTTTTGGAATACTTAGTATTACAAATAACGATTTTTA
TTCATCTTACAAAGGATATATAATGTACTGAAGGCAATTTTTATGTATCACAAA
TCTAATTGTATATGTAAAGTTTTGATAAATATCATTAATTTTACATAACTATCA
TTAGATTACAAATCACAATGTAATTACATGTAATACACATCTACACATCACATT
TGAAGGGAAATGAATATAAATG
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To our surprise SrrA bound the DNA (Fig. 4.8A). Upon review of the sequence of the 1266 
alsSD promoter we found several putative SrrA binding sites downstream of the -35 and -1267 
10 elements, suggesting that SrrA binding in that location could disrupt transcription, act-1268 
ing as a repressor. We reviewed our data to find a reason for the discrepancy between 1269 
SrrA binding and a lack of an effect on alsSD transcription. SrrAB can act as a regulator 1270 
during aerobic conditions (84), as evidenced by the results of our stationary phase surviv-1271 
al assays and beta-galactosidase assays. Nonetheless SrrAB is traditionally considered to 1272 
be an anaerobic regulator (67, 81, 83). We reasoned then that since SrrAB activity would 1273 
be more pronounced under conditions of low oxygen (84), SrrAB mediated repression of 1274 
alsSD transcription would be more apparent under microaerobic conditions (Fig. 4.9). We 1275 
found that when grown microaerobically with excess glucose, the induction of alsSD is 1276 
not affected in a significant manner by disruption of srrAB (Fig. 4.9A). However, when 1277 
grown without excess glucose under microaerobic conditions alsSD finally demonstrated 1278 
a SrrAB-dependent phenotype. These results indicate that SrrAB does act as a repressor 1279 
of alsSD, albeit in a very weak fashion.  1280 
 1281 
89 
 
 1282 
Figure 4.9: SrrAB represses cidABC and alsSD under microaerobic conditions. The expression of  1283 
cidABC and alsSD  in the srrAB mutant background under microaerobic conditions, 3 to 5 media to flask 1284 
ratio for 24 hours before samples were assayed for β-galactosidase activity. A. Cultures were grown in 1285 
NZY + 35 mM glucose. B. Cultures were grown in NZY (no glucose).  Data are the average of at least two 1286 
separate experiments. 1287 
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The lrgAB and lytSR operons play a role in sensitivity to exogenous ROS  1288 
 It has been demonstrated that disruption of the ΔlrgAB and ΔlytSR operons in Strep-1289 
tococcus mutans results in increased sensitivity to H2O2 (83). We reasoned that ΔlrgAB 1290 
and ΔlytSR mutants would show the same phenotype in S. aureus.  Indeed, our investiga-1291 
tions of the S. aureus ΔlrgAB and ΔlytSR operons revealed a similar increase in sensitivi-1292 
ty to this ROS (Fig. 4.10). Since ΔcidA and ΔcidB decrease sensitivity to ROS in a 1293 
ΔsrrAB mutant (Fig. 4.4E), it is interesting then that cidAB and lrgAB have opposing 1294 
phenotypes when it comes to sensitivity to exogenous ROS. 1295 
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 1296 
Figure 4.10. UAMS-1 ΔlrgAB and ΔlytSR mutants display increased sensitivity to ROS. Overnight 1297 
cultures were resuspended to an OD600 of 0.06 in TSB. Cultures were challenged with 5 mM H2O2 and 1298 
growth was monitored for 24 hours at 37°C in a Tecan infinite 200 spectrophotometer under maximum 1299 
aeration.  1300 
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Discussion 1301 
The results generated in this study demonstrate that the SrrAB two-component system 1302 
functions to directly repress expression of the cidABC operon under conditions of excess 1303 
glucose (Fig. 4.2B-C), resulting in the suppression of cell death. The decreased stationary 1304 
phase survival of the srrAB mutant is not due to changes in the levels of acetate or chang-1305 
es in the pH (Fig. 4.1B-C), but instead the result of increased sensitivity of this strain to 1306 
acetate-dependent ROS (Fig. 4.3). Importantly, this study revealed for the first time the 1307 
critical role of cidB in this process.  1308 
Previous studies performed by our laboratory have reported that the S. aureus cidC-1309 
encoded pyruvate oxidase plays a critical role in cell death during stationary phase under 1310 
excess glucose conditions (60) by producing acetate and promoting the acidification of 1311 
the growth media (61). Thus, given that cidABC transcription was enhanced in a ΔsrrAB 1312 
mutant (Fig. 4.2B) (83), we initially hypothesized that the decreased survival of these 1313 
cells was due to increased acetate, which would in turn lead to cytoplasmic acidification 1314 
and ROS accumulation. However, the results of the current study revealed that this phe-1315 
notype was clearly not associated with increased acetate accumulation or decreased pH of 1316 
the culture medium (Fig. 4.1B-C). Instead, experiments where the cultures were switched 1317 
to anaerobic conditions (Fig. 4.3B) suggested that the decreased stationary phase survival 1318 
of the ΔsrrAB mutant was due to increased sensitivity to the acetate-dependent generation 1319 
of ROS. 1320 
Acetate potentiates cell death via a complicated process (61). When the pH of the en-1321 
vironment surrounding the cell is higher than the pKa of acetate (~4.8), most of the ace-1322 
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tate is unprotonated and has a negative charge (61), allowing the cell membrane to act as 1323 
a barrier to entry. As the extracellular pH decreases and approaches the pKa of acetate 1324 
there is an increased percentage of acetate that is protonated to acetic acid. Now neutrally 1325 
charged, the acetic acid can diffuse across the membrane into the bacterial cytoplasm. 1326 
Once across the membrane the protons disassociate from acetic acid, leading to a de-1327 
crease in the intracellular pH and, through an unknown mechanism, an increase in the 1328 
accumulation of ROS. Over time, this leads to increasing amounts of cellular damage and 1329 
cell death. It has been suggested that acetate may contribute to a bottleneck in electron 1330 
transport by reducing the functionality of the respiratory chain and catalyzing the reduc-1331 
tion of oxygen, resulting in the production of ROS (61), but it is not clear how acetate 1332 
initiates ROS production at the molecular level. Interestingly, the disruption of cidB im-1333 
proved both stationary phase survival (Fig. 4.4B) and sensitivity to H2O2 (Fig. 4.4E), im-1334 
plicating the involvement of cidB in these processes. Importantly, any involvement of 1335 
catalase or superoxide dismutase seems unlikely as there was no alteration in the expres-1336 
sion of the genes encoding these enzymes in the ΔsrrAB mutant (Fig. 4.6B). Thus, the 1337 
ΔsrrAB mutant background may be an important genetic context in which the role of 1338 
CidB manifests itself as a direct mediator of cell death in the response to ROS.  1339 
Although the model for CidAB and LrgAB function up to now has focused primarily 1340 
on the CidA and LrgA proteins as a holin and antiholin, respectively, the results present-1341 
ed here, as well as recent data generated by our laboratory, has cast this system in a dif-1342 
ferent light. Although an early report suggested that the cidB gene can affect the expres-1343 
sion/activity of a 25-30 kDa murein hydrolase (126), little is known about CidB and LrgB, 1344 
other than that they are predicted to be ~25 kDa membrane-associated proteins (50, 126). 1345 
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The results of the current studies indicate that in the context of the ΔsrrAB mutation, dis-1346 
ruption of cidB has a dramatic effect on stationary phase survival (Fig. 4.4B), but only a 1347 
modest effect on acetate secretion (Fig. 4.4C) and culture pH (Fig. 4.4D). Importantly, 1348 
ongoing studies in our laboratory indicate that CidB plays a positive role in the regulation 1349 
of CidC activity and acetate secretion (unpublished data). Combined with the studies pre-1350 
sented here, these results suggest that CidB may have a more impactful role in the cell 1351 
death pathway and acetate metabolism than had been previously recognized.  1352 
The survival of the ΔsrrAB ΔcidB mutant under anaerobic conditions confirms that 1353 
CidB plays a role in sensitivity to ROS (Fig. 4.6). Growth under anaerobic conditions al-1354 
lows us to differentiate between the effects of ROS and the effects of acid stress concern-1355 
ing cell death. The ΔsrrAB ΔcidC and ΔsrrAB ΔcidB do not display the same phenotype 1356 
under anaerobic conditions, demonstrating that over-expression of CidB leads to sensitiv-1357 
ity to ROS in the srrAB background. Interestingly, on the 4
th
 day of stationary phase the 1358 
ΔsrrAB ΔcidB mutant experiences a sudden decrease in viability, after which the viability 1359 
of the ΔsrrAB ΔcidB mutant is indistinguishable from the ΔsrrAB ΔcidA mutant. Under 1360 
aerobic conditions the ΔsrrAB ΔcidB shows an increase in the pH within this time frame 1361 
(Fig. 4.4D). This could indicate that CidB plays an important role in resistance to weak 1362 
acid stress at this time point. This would make some sense given that it has been pro-1363 
posed that CidB acts as a transporter for the acetate produced by CidC (work in progress 1364 
by Vinai Thomas). It could be that the presence of the acetate transporter is required for 1365 
long term resistance to weak acid stress under anaerobic conditions. 1366 
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In addition to the effect of the cidB mutation on H2O2 sensitivity, this study revealed 1367 
that the disruption of cidA also decreased the sensitivity of the ΔsrrAB mutant to H2O2 1368 
(Fig. 4.4E). In contrast to these findings, disruption of the Streptococcus mutans ΔlrgAB 1369 
and ΔlytSR operons were previously shown to cause increased sensitivity to H2O2 (83). 1370 
Our investigations of the S. aureus ΔlrgAB and ΔlytSR operons revealed a similar in-1371 
crease in sensitivity to this ROS (Fig. 4.10). With respect to the H2O2 phenotype, it is in-1372 
teresting to note that SrrAB and LrgAB have a negative effect on cidABC; SrrAB re-1373 
presses cidABC expression at the transcriptional level, and LrgA has been proposed to 1374 
inhibit CidA activity as an antiholin (42). Although we did not observe altered ROS sen-1375 
sitivity resulting from cidA or cidB mutations in the wild-type background (data not 1376 
shown), this is likely due to the fact that cidABC expression is repressed by the SrrAB 1377 
regulatory system in this genetic context. Overall, these results are consistent with the 1378 
model in which the cid and lrg operons play opposing roles in cell death 1379 
Although we noted that cidABC expression is increased nearly four-fold in the 1380 
ΔsrrAB mutant background (Fig. 4.2B), a corresponding increase in extracellular acetate 1381 
levels was not observed (Fig. 4.1B). One explanation for this is that under these condi-1382 
tions an alternative pathway, the pta-ackA pathway (72), produces most of the acetate in 1383 
the ΔsrrAB mutant. Alternatively, while we have focused on cidABC transcription in this 1384 
study, the cid operon also produces a cidBC transcript, whose expression is regulated by 1385 
sigma factor B, independently of CidR (51). Since the cidBC transcript is highly elevated 1386 
when there is excess glucose (51), it is possible that the increase in cidABC transcription 1387 
does not result in a significant increase in CidC protein levels and as a result, acetate pro-1388 
duction. The elevated cidBC transcript could also be the reason that there is a large dif-1389 
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ference in the ROS detected in ΔsrrABΔcidA mutant compared to the ΔsrrABΔcidB and 1390 
ΔsrrABΔcidC mutants (Fig. 4.4A). These possibilities are currently under investigation.  1391 
It is also interesting to note that while the ΔsrrAB mutant has previously been shown 1392 
to exhibit poor growth under anaerobic conditions (81), we have demonstrated that it sur-1393 
vives better in stationary phase under these conditions compared to the wild-type strain 1394 
(Fig. 4.3B). These data suggest that SrrAB necessary for anaerobic growth, but converse-1395 
ly may be detrimental to survival within an anaerobic environment. It has been suggested 1396 
that the decreased expression of genes involved in anaerobic metabolism may be respon-1397 
sible for the altered growth and survival of the ΔsrrAB mutant under these conditions 1398 
(84). For example, the discrepancy between growth and survival could be explained by 1399 
the deregulation of the nrdDG and nar operons (83). The nrdDG operon encodes 1400 
ribonucleoside-triphosphate reductase, essential for anaerobic growth (127); thus, the de-1401 
creased expression of nrdDG in a ΔsrrAB mutant (83) would lead to poor growth under 1402 
low oxygen conditions. On the other hand, the nar genes (nitrate reductase) are repressed 1403 
by SrrAB (83), so increased expression could lead to greater consumption of nitrate, a 1404 
more active electron transport chain and more energy for the cell, potentially allowing for 1405 
better survival during stationary phase under anaerobic conditions in a ΔsrrAB mutant.  1406 
Given that our initial data would suggest that SrrAB does not regulate alsSD (Fig. 1407 
4.7A), the discovery that disrupting srrAB increased acetoin concentration in the superna-1408 
tant was interpreted as a redirection of carbon and not necessarily alsSD transcription. 1409 
However, we found that SrrA binds the alsSD promoter (4.8A). Further investigation re-1410 
vealed that SrrAB represses alsSD, but only under microaerobic conditions without ex-1411 
97 
 
cess glucose (Fig. 4.9). The answer to this confusing result is suggested by comparing the 1412 
EMSAs of SrrA binding between the two promoters. SrrA creates a shift in the cidABC 1413 
promoter at 0.25 µM (Fig. 4.2C), whereas the alsSD shift does not occur until 0.5 µM of 1414 
purified SrrA (Fig. 4.8B). While we have not performed experiments looking into the dis-1415 
sociation constant of SrrA to its target DNA, these EMSAs would suggest that SrrA has 1416 
lower affinity for the alsSD promoter compared to the cidABC promoter. The affinity is 1417 
so weak that repression is easily overpowered by CcpA and CidR-mediated up-regulation 1418 
of alsSD, so SrrAB-mediated regulation of alsSD is noticeable only when there is no glu-1419 
cose and the signal to which SrrAB responds is strong. By contrast then, SrrAB-mediated 1420 
repression in the cidABC promoter would not be as easily overpowered, making a sizable 1421 
difference in cidABC induction even under aerobic conditions when CidR and CcpA are 1422 
active.  1423 
In conclusion, our results indicate that the disruption of the srrAB regulatory operon 1424 
in S. aureus results in reduced stationary phase viability due to the increased production 1425 
and sensitivity to ROS. The ROS are formed in the presence of acetic acid produced by 1426 
CidC encoded by the cidABC operon, which is repressed by SrrAB. Furthermore, we 1427 
demonstrate that the increased cell death observed in the ΔsrrAB mutant is dependent on 1428 
cidB. These results are the first to demonstrate a role for cidB in cell death and provide 1429 
greater insight into the functions of the cidABC-encoded proteins, as well as the transcrip-1430 
tional control of this cell death regulatory system.  1431 
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Chapter V. Concluding remarks 1432 
cidABC 1433 
The cid operon consists of the cidA, cidB and cidC genes, organized into two over-1434 
lapping transcripts, the cidABC transcript (3.0 Kb) and the cidBC transcript (2.7 kb). It 1435 
has been published previously that cidABC expression is positively regulated by CidR (31, 1436 
50).  Experiments performed for this dissertation found that cidABC transcription is also 1437 
under positive regulation by CcpA (Chapter 3), and negative regulation by SrrAB (Chap-1438 
ter 4). The binding site of CcpA, the cre site, lies -80 to -73 bp upstream of the transcrip-1439 
tion start site. The CidR binding site is located 7 bp downstream of the cre site. The SrrA 1440 
binding site lies downstream of the transcription start site, suggesting that repression is 1441 
the result of impeding the activity of RNA polymerase. The production of the cidBC tran-1442 
script is up-regulated by sigma factor B (51). As a result the increase in induction from 1443 
the cidABC promoter does not significantly change the expression of the cidB and cidC 1444 
genes (work in progress by Vinai Thomas). This could indicate that SrrAB-mediated re-1445 
pression effectively decreases the expression of the cidA gene only. If true, this suggests 1446 
that SrrAB-mediated repression of cidABC transcription is to reduce stress to the cell cre-1447 
ated by CidA.  1448 
The genes of the cid operon are involved in the modulation of cell death. In our cur-1449 
rent understanding, CidA is a holin, based on its sequence similarities with bacteriophage 1450 
holins and holin-like properties (50, 53). It has been theorized that CidA localizes to the 1451 
cell membrane, forming pores by oligomerization. These pores have been proposed to 1452 
lead to membrane depolarization, activating murein hydrolase activity and leading to cell 1453 
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lysis (56).  The cid operon also influences cell death metabolically through CidC, a py-1454 
ruvate oxidase (60) that potentiates cell death during stationary phase and biofilm devel-1455 
opment through the production of acetic acid (61). Due to the results of the experiments 1456 
detailed in this dissertation it was discovered that CidB also plays a role in influencing 1457 
staphylococcal cell death (104). Disruption of cidB restored the viability of the ΔsrrAB 1458 
mutant culture in stationary phase (Fig. 4.4B) and sensitivity of the ΔsrrAB mutant to ex-1459 
ogenous ROS (Fig. 4.4E). Unusually, disruption of cidB in the wild-type background 1460 
does not produce as strong a phenotype. Acetate production was slightly decreased, but 1461 
the effect on stationary phase survival, ROS production and ROS sensitivity was not ob-1462 
served (data not shown). These results suggest that the srrAB mutant background pro-1463 
vides a genetic context in which the function of CidB manifests itself.  1464 
 1465 
alsSD 1466 
Like cidABC, the transcription of alsSD is also positively regulated by CidR (64), and 1467 
the experiments performed in this dissertation found that positive regulation by CcpA and 1468 
negative regulation by SrrAB. The alsSD promoter contains multiple cre-like sites that 1469 
CcpA could potentially bind, the first from -90 to -83, and the second from -64 to -57 bp 1470 
upstream of the putative transcription start site. The alsSD promoter also has two putative 1471 
SrrA binding sites downstream of the transcription start site. Like the SrrA binding site in 1472 
the cidABC promoter, the binding sites in the alsSD promoter are in a position that sug-1473 
gests binding could interfere with RNA polymerase function. 1474 
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The genes in the alsSD operon, organized into a single 2.5 Kb transcript, play a role 1475 
in modulating cell death. The genes in the als operon are α-acetolactate synthase (alsS) 1476 
and α-acetolactate decarboxylase (alsD). AlsS and AlsD synthesize acetoin, which has a 1477 
role in promoting cell survival (61, 64). Since the activity of both AlsSD and CidC act to 1478 
deplete pyruvate pools, it therefore seems likely that AlsSD and CidC act as part of the 1479 
carbon overflow mechanisms of the cell (61, 100). 1480 
 1481 
Individual regulators 1482 
CidR 1483 
CidR is an LTTR, a LysR-type transcriptional regulator (65). LTTRs are often 1484 
thought of as global transcriptional regulators (87), controlling metabolic genes (128), 1485 
virulence determinants and quorum sensing (129). However, microarrays performed to 1486 
determine the regulatory targets of S. aureus CidR found that disrupting the cidR gene 1487 
affected expression of only the cidABC and alsSD operons (64). In agreement with this 1488 
finding, the 5’-TAGTA-A/T-TACAAA-3’ sequence occurs only in the promoters of 1489 
cidABC and alsSD in the S. aureus genome (data not shown). Despite controlling only 1490 
two operons, CidR is widely conserved. A study was conducted screening for homologs 1491 
of all 125 transcriptional regulators in S. aureus across more than 1,200 different Gram-1492 
positive and Gram-negative bacterial species genomes (130). It was determined that CidR 1493 
was the third most common transcriptional regulator, after sigma factor A and HU. These 1494 
results suggest that the processes that CidR controls have deep ancestral roots and under-1495 
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score the need to understand the operons it controls and the signals to which CidR re-1496 
sponds.  1497 
 1498 
CcpA 1499 
CcpA is the primary mediator of CCR in Gram-positive bacteria like S. aureus (74, 1500 
75), affecting the expression of hundreds of genes (73, 74). CcpA responds to fructose-1501 
1,6-bisphosphate and glucose-6-phosphate levels, which promote the association of 1502 
phosphorylated Hpr with CcpA (74).  The CcpA-Hpr complex then regulates target genes 1503 
by binding to cre sites (67). Though the process is termed CCR (the “R” referring to “re-1504 
pression”), CcpA can act as a positive regulator when it binds to a cre site upstream of 1505 
the promoter (74), as is the case with cidABC and alsSD. In S. aureus CcpA represses the 1506 
TCA cycle in the presence of glucose (67, 73, 131), leading to the accumulation of py-1507 
ruvate and acetyl-CoA. CidC and AlsSD act to deplete pyruvate pools (60), while 1508 
Pta/AckA deplete acetyl-CoA (72), suggesting that the up-regulation of cidABC and 1509 
alsSD is a component of the response to carbon overflow within the cell (61, 100).  1510 
 1511 
SrrAB 1512 
SrrAB is a homologue of the two-component system ResDE, essential in many Gram-1513 
positive bacteria for anaerobic respiration (67, 80). Despite being essential for anaerobic 1514 
respiration, the exact signal that SrrAB responds to is unknown. Due to the fact that de-1515 
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creased menaquinone production results in decreased srrAB expression (132) and that 1516 
SrrAB responds to both nitric oxide stress and oxygen availability (81, 83), it has been 1517 
proposed that SrrAB detects changes in the redox status of the electron transport chain by 1518 
sensing reduced menaquinone, though this has not yet been proven. Under anaerobic 1519 
conditions, to restore redox balance S. aureus produces lactate via L-lactate dehydrogen-1520 
ase (ldh) (61, 79), consuming NADH. This suggests that repression of cidABC (104) and 1521 
alsSD expression (Chapter 4) is a means of redirecting carbon to lactate. This is con-1522 
sistent with the fact that although the creation of 2,3-butanediol by acetoin reductase 1523 
(butA) also consumes NADH (56), S. aureus does not synthesize acetoin under anaerobic 1524 
conditions (data not shown).  1525 
 1526 
Current understanding 1527 
The current understanding of what is occurring in cid-mediated cell death is depicted 1528 
in Figure 5.1. To begin, glucose enters the cell via the phosphotransferase system (67, 74, 1529 
76). During translocation into the cell, glucose is phosphorylated to glucose 6-phosphate 1530 
to enter glycolysis. Glucose 6-phosphate is then converted to fructose 1,6 bis-phosphate. 1531 
High levels of fructose 1,6 bis-phosphate lead to phosphorylation and activation of HprK 1532 
kinase (77, 78), which then phosphorylates Hpr (74). Fructose 1,6-bisphosphate and glu-1533 
cose 6-phosphate then promote the association of the phosphorylated Hpr and CcpA. 1534 
Once associated, the CcpA-Hpr complex can then bind to cre sites to mediate CCR.  1535 
 1536 
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 1537 
Figure 5.1. Current understanding of the process of cid-mediated cell death. Depicted are the cidABC 1538 
and alsSD operons, the proteins produced by these operons and their known function, the transcriptional 1539 
factors involved in regulation of cidABC and alsSD and the stimuli they respond to. Due to the importance 1540 
of excess glucose and CCR to induction of cidABC and alsSD, the phosphotransferase system, glycolysis 1541 
and the TCA cycle are included. Acetate and its role in cell death (61) are included. For more in depth de-1542 
scription see the main text.  1543 
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In S. aureus, one of the processes repressed by CCR in the presence of glucose is the 1548 
TCA (67, 73, 131), leading to the accumulation of pyruvate and acetyl-CoA. The pools of 1549 
pyruvate and acetyl-CoA must be depleted to continue glycolysis, so carbon overflow 1550 
mechanisms are activated, including CidC and AlsS/AlsD. The activity of CidC and 1551 
AlsS/AlsD acts to consume pyruvate by converting it to acetate (60) and acetoin, respec-1552 
tively. Acetyl-CoA is converted to acetate by Pta/AckA (72). Once generated, the acetate 1553 
and acetoin are excreted from the cell to be consumed later. 1554 
The breakdown of excess glucose leads to the induction of the cidABC operon 1555 
through CidR-mediated regulation responding to increasing concentrations of an un-1556 
known co-inducer molecule. While CidC acts to deplete pyruvate, the cidABC operon 1557 
contributes to the overall stress of the cell. The current model suggests that CidA localiz-1558 
es to the cell membrane, oligomerizing and forming pores. These pores lead to membrane 1559 
depolarization, which activates murein hydrolase activity, leading to cell lysis (56). The 1560 
role of CidB during this time period is unclear because the mechanism of CidB is not yet 1561 
understood. Nonetheless, our data suggests that CidB plays a role in creating ROS sensi-1562 
tivity in the cell, which could also lead to stress and ultimately lysis.  1563 
In addition, glycolysis results in increased cytoplasmic levels of NADH (67). Since 1564 
elevated levels of NADH can inhibit biosynthetic pathways (67), the redox balance must 1565 
be restored. This can be partially accomplished by AlsS/AlsD; the acetoin produced from 1566 
pyruvate can be processed further by acetoin reductase to create 2,3-butandiol and NAD
+
 1567 
(56). This can partially restore redox balance, but to convert high concentrations of 1568 
NADH to NAD
+ 
requires increasing the activity of the electron transport chain. However, 1569 
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increased respiration also produces increased ROS (133-135), which in turn leads to in-1570 
creased cell stress.  1571 
Cellular stress also comes from the acetate released into the environment. The in-1572 
creased levels of acetate produced by CidC in the presence of excess glucose lowers the 1573 
extracellular pH. As the pH of the extracellular environment decreases and approaches 1574 
the isoelectric point of the weak acid, an increasing percentage of the acetate molecules 1575 
become protonated to acetic acid (61), and can diffuse across the cell membrane. Once 1576 
inside the acetic acid causes acidification of the cytoplasm and increased ROS formation, 1577 
further contributing to stress that can lead to the death of the cell.  1578 
In a biofilm the cellular stresses created by cidABC are further modulated by the het-1579 
erogeneity of the biofilm. The rapid mixing of metabolites observed in liquid culture does 1580 
not occur in a biofilm because the diffusion of metabolites in a biofilm is reduced by mi-1581 
crobial cells and the extracellular matrix (136). This creates localized niches that exhibit 1582 
variable metabolite concentrations throughout the biofilm. The altered diffusion leads to 1583 
localized pockets of high concentrations of glucose, acetate, and low pH, resulting in in-1584 
creased cell death in these regions. Therefore in a biofilm one would predict that thicker 1585 
regions of the biofilm provides more opportunities for metabolite accumulation and 1586 
greater induction of cidABC and alsSD, leading to increased cell death and lysis and re-1587 
lease of eDNA into the environment. This prediction is supported by the induction of 1588 
cidABC is increased in the thick towers formed by a biofilm, which also correlates with 1589 
the presence of eDNA (99).  1590 
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The heterogeneous environment within a biofilm also effects the diffusion and con-1591 
sumption of oxygen. Oxygen is consumed by the surface layer of cells, resulting in hy-1592 
poxic conditions deeper within the biofilm (99). Reduced oxygen conditions promotes 1593 
glycolysis in the deeper cells (137) if glucose penetrates deep enough, leading to in-1594 
creased CCR and cidABC induction and cell lysis. Low oxygen also leads to increased 1595 
repression by SrrAB (81) potentially reducing cidABC and alsSD induction. 1596 
 1597 
Remaining questions and future directions 1598 
The identity of the co-inducer molecule of CidR  1599 
Despite the efforts detailed within this dissertation, the identity of the co-inducer 1600 
molecule of CidR remains unknown. The original planned approach included three spe-1601 
cific aims: 1) mutagenize the cidABC and alsSD promoter regions to identify the CidR 1602 
binding site; 2) employ transposon mutagenesis to identify metabolic pathways that effect 1603 
the induction of cidABC transcription; and 3) use DNA-protein interaction experiments to 1604 
identify the CidR co-inducer. While Aims 1 and 2 led to the discovery of the CidR bind-1605 
ing site and CCR as an affecter of cidABC and alsSD expression, the attempts at Aim 3 so 1606 
far have not proven successful. Despite attempting multiple potential co-inducer mole-1607 
cules under multiple conditions the EMSA experiments performed have not revealed the 1608 
identity of the co-inducer molecule (data not shown). As stated above, LTTRs regulate 1609 
the target promoter by bending the DNA (87). An EMSA proving the identity of the co-1610 
inducer molecule is predicated on the LTTR making a big enough change in DNA bend-1611 
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ing in the presence of the co-inducer that this would be noticeable in an EMSA (97). If 1612 
the bend is not big enough, the EMSA will not be sensitive enough to determine the iden-1613 
tity of the co-inducer molecule. In a more sensitive experiment, a DNase I footprinting 1614 
assay the LTTR binding the co-inducer molecule would be visualized as a change in the 1615 
footprint position. An alternative to DNase I footprinting would be to use an in vitro tran-1616 
scription assay. Purified CidR, CcpA and RNA polymerase would be added to purified 1617 
plasmid containing the cidABC promoter. Putative co-inducer molecules would be added 1618 
to determine which molecule increases cidABC transcription.  1619 
Another alternative strategy to identify the CidR co-inducer would be to use a gel fil-1620 
tration analysis of CidR in the presence of different candidate molecules. It was recently 1621 
demonstrated that the LTTR, CcpE, oligomerizes in the presence of its co-inducer mole-1622 
cule, citrate (128). Ordinarily, CcpE exists in solution as a 66 kDa dimer. However, when 1623 
citrate is added, CcpE oligomerizes to form a 132 kDa tetramer. The same experiment 1624 
could be attempted with CidR with potential co-inducer molecules at varying concentra-1625 
tions. Although this approach would inform us about the effects of these molecules on the 1626 
oligomerization state of CidR, additional experiments would be required to demonstrate 1627 
that these physical changes are sufficient to induce transcription. 1628 
An additional alternative would be to crystallize CidR and determine what molecule 1629 
is bound in the co-inducer binding domain of this protein. While this technique has been 1630 
used for some LTTRs (138, 139), protein crystallization is a long and intensive process, 1631 
made worse by the fact that LTTRs are notoriously difficult to crystallize (87, 140).  1632 
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Although attempts to identify the co-inducer for CidR have been unsuccessful thus far, 1633 
there is conflicting evidence to suggest that it is pyruvate. Disruption of the ackA/pta 1634 
genes results in a more than 40-fold increase in cidABC transcription, which correlates 1635 
with 4-fold increase in pyruvate concentration (72). The experiment shown in Figure 3.9 1636 
demonstrates that a carbon source that does not induce CCR does not induce cidABC or 1637 
alsSD transcription. One explanation for this is that CCR represses the TCA cycle, lead-1638 
ing to an increase in intracellular pyruvate and the induction of CidR-mediated transcrip-1639 
tional control. Given that cidC and alsSD appear to play a role in carbon overflow by de-1640 
pleting pyruvate pools (72), it would make sense that pyruvate would act as the signal for 1641 
CidR to begin upregulation of the operons that would lead to pyruvate’s depletion. On the 1642 
other hand, it was found that the addition of acetic acid or lactic acid can increase cidABC 1643 
expression, but pyruvic acid did not (141). Ultimately, success with the proposed experi-1644 
ments described above will be required to determine the identity of the co-inducer mole-1645 
cule. 1646 
The difficulty encountered in identifying a co-inducer molecule for CidR raises the 1647 
possibility that CidR does not possess one. There are LTTRs for which this is known to 1648 
be the case (87, 142). However, this is unlikely for CidR since the up-regulation of target 1649 
genes by a co-inducerless LTTRs require that expression of the LTTR be variable and 1650 
CidR is constitutively expressed (65). Furthermore, the timing of cidABC induction sug-1651 
gests that there is a co-inducer molecule. CCR starts within 30 minutes of the addition of 1652 
glucose (143). CcpA would then be bound to the DNA of the cidABC and alsSD promot-1653 
ers. However, cidABC induction is not seen until three to four hours of growth with ex-1654 
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cess glucose (98). Since cidR is constitutively expressed (65), there must be another fac-1655 
tor involved.  1656 
 1657 
Physical interaction between CidR and CcpA  1658 
Chapter 3 demonstrated that both CcpA and CidR directly bind and up-regulate ex-1659 
pression of the cidABC and alsSD promoters (Fig. 3.4 and 3.6). In both promoters cre 1660 
sites are located upstream of the CidR-binding sites. The close proximity of the binding 1661 
sites raises the possibility that the two proteins physically interact with one another, that 1662 
physical interaction between CcpA and CidR is required for up-regulation of cidABC and 1663 
alsSD transcription. In at least one instance it has been proposed that an LTTR physically 1664 
interacts with another protein for induction (144). If this is indeed the case for CidR it 1665 
would be the second known LTTR to do so. Yeast two-hybrid assays could be employed 1666 
to determine if these physical interactions occur. Alternatively, in vivo crosslinking anal-1667 
ysis or in vitro pulldown assays could be employed.  1668 
 1669 
The role of CidB in acetate metabolism, ROS sensitivity and cell death  1670 
Disrupting cidB restored the viability of the ΔsrrAB mutant culture in stationary 1671 
phase (Fig. 4.4B), as well as rescued the increased sensitivity of this mutant to exogenous 1672 
ROS (Fig. 4.4E). Restoration of the normal ΔsrrAB mutant phenotypes by expressing 1673 
cidB from a plasmid (Fig. 4.5C) indicated that the phenotypes displayed were in fact due 1674 
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to CidB and not a polar effect on cidC. In contrast, disrupting the cidB gene in the wild-1675 
type background alters acetate production, but does not have an effect on ROS production, 1676 
ROS sensitivity, and stationary phase survival (data not shown). These results suggest 1677 
that the srrAB mutant background provides a genetic context in which the CidB protein 1678 
functions.  1679 
The identification of a genetic context in which cidB function manifests itself pro-1680 
vides an opportunity to study its function in greater detail. Studies will be conducted to 1681 
determine the function of CidB. For example, cidB could be overexpressed in wild-type 1682 
cells to determine if over-expression of cidB alone, and not altered expression of other 1683 
genes in the SrrAB regulon, results in increased sensitivity to hydrogen peroxide and 1684 
poor stationary phase survival. In addition, one could determine if the proteins of the 1685 
cidABC operon interact with each other, using yeast two-hybrid assays in vivo crosslink-1686 
ing analysis or in vitro pulldown assays. This type of experiment could be used to deter-1687 
mine how CidA and CidB effects acetate production and consumption. 1688 
 1689 
Why does ΔsrrAB exhibit increased sensitivity to ROS?  1690 
Chapter 4 demonstrated that the ΔsrrAB mutant displayed an increased sensitivity to 1691 
ROS (Fig. 4.3C). One possibility that was considered was that the ΔsrrAB mutation ef-1692 
fects expression of ROS detoxifying genes such as superoxide dismutase (sod) and cata-1693 
lase (kat). However, transcription studies revealed that there was no difference between 1694 
the ΔsrrAB mutant and wild-type in the expression of these genes when exposed to hy-1695 
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drogen peroxide (Fig. 4.6A). Thus, the decreased viability of the ΔsrrAB mutant in sta-1696 
tionary phase is not likely to be a function of deficiencies in known responses to oxida-1697 
tive stress. Another possible explanation for the decreased viability of the ΔsrrAB mutant 1698 
in stationary phase is that this mutation causes increased ROS production due to in-1699 
creased activity of the electron transport chain. The SrrAB two-component system regu-1700 
lates multiple genes involved in the electron transport chain (83, 84), which can produce 1701 
ROS as a consequence of the normal activity of these proteins (134, 135). Indeed, there is 1702 
a slight increase in the concentration of ROS in the ΔsrrAB mutant relative to the wild-1703 
type strain (Fig. 4.3A). Increased respiratory activity could be due to de-repression of the 1704 
nar genes, which are required for the use of nitrate as a terminal electron acceptor (79).  1705 
To determine if there is increased respiration, assays detecting oxygen or nitrate con-1706 
sumption could be employed. qRT-PCR or promoter fusions reporters could also be used 1707 
to determine if SrrAB-regulated genes encoding components of the electron transport 1708 
chain are induced.  1709 
 1710 
What are the roles played by the genes identified in a transposon mutagenesis screen in 1711 
the induction of cidABC and alsSD expression?  1712 
In an effort to reveal the co-inducer molecule of CidR, we performed transposon mu-1713 
tagenesis using a PcidABC::lacZ reporter strain to identify genes that affect production of 1714 
the CidR co-inducer. This screen revealed two mutants that increased cidABC expression 1715 
under non-inducing conditions, and 12 that decreased expression under inducing condi-1716 
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tions (Table 4). We then took those recovered mutants and confirmed altered cidABC in-1717 
duction by quantitative β-galactosidase assays to verify positive hits. 1718 
 One of the genes found by the transposon mutagenesis screen to have an effect on the 1719 
expression of cidABC was acetate kinase (ackA).  The ΔackA mutant has previously been 1720 
shown to exhibit increased cidABC expression (72), which provided confidence that the 1721 
assay was working as predicted. The other mutation that increased cidABC induction was 1722 
phosphoglucomutase (pgcA), which is active in the glycolysis, pentose phosphate and 1723 
purine synthesis pathways. Many of the mutants recovered appear to have a role in cen-1724 
tral metabolism, suggesting that the reason that cidABC expression was altered was due 1725 
to redirection of carbon, resulting in depletion of the pool of carbon. HPr (ptsH) and PEP 1726 
phosphotransferase (ptsI) are genes involved in the phophotransferase system, and CCR 1727 
via the interaction of HPr with CcpA. Glucokinase (glk) is involved in glycolysis, 6-1728 
phosphogluconolactonase (SAUSA300_1902) in the pentose phosphate pathway, and 1729 
inosine 5’ dehydrogenase (guaB) in the purine synthesis pathway. 1730 
However, there were a number of mutants in genes recovered in which it is difficult 1731 
to determine how they would alter cidABC expression. SAUSA300_1624, as a member 1732 
of the mut/nudix family of proteins, is probably a house-keeping enzyme, but what it 1733 
could be affecting is unknown. SAUSA300_2021 is a metallopeptidase of the SprT fami-1734 
ly of proteins, which may have a role in transcription elongation. SAUSA300_0495 is a 1735 
hypothetical protein with no known protein motifs. The glucose-inhibited division protein 1736 
A gene (gidA) is a tRNA uridine 5-carboxymethylaminomethyl modification enzyme. 1737 
Cytochrome oxidase assembly protein (ctaA) is important to the function of the electron 1738 
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transport chain. The preprotein translocase (secY) was found to decrease cidABC induc-1739 
tion, but what protein it could be translocating that would have an effect on cidABC tran-1740 
scription is unknown. Likewise, ribonuclease R (rnr) is a component of the bacterial 1741 
RNA degradation system, but is involved in a regulation of a large number of processes 1742 
(145), and so it is unclear what it is regulating that alters cidABC transcription.  It is pos-1743 
sible that these genes have an indirect effect on central metabolism. To determine this the 1744 
concentration of metabolites, such as pyruvate, will need to be measured.   1745 
 1746 
During the course of this study it became obvious that the more we investigated the 1747 
regulation of cid-mediated cell death, the more complex it became. In retrospect, this is 1748 
not surprising, as this regulatory system controls a process that determines the fate of the 1749 
cell, not unlike apoptosis in eukaryotes. Thus, much like apoptosis, one would expect the 1750 
regulation of cid-mediated cell death to be complicated. Clearly, much more research is 1751 
required before a full understanding of this system can be reached. 1752 
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